<!DOCTYPE html>
<html lang="en" dir="ltr" class="client-nojs">
<head>
<meta charset="UTF-8" />
<title>Hypercholesterolemia - Wikipedia, the free encyclopedia</title>
<meta name="generator" content="MediaWiki 1.26wmf13" />
<link rel="alternate" href="android-app://org.wikipedia/http/en.m.wikipedia.org/wiki/Hypercholesterolemia" />
<link rel="alternate" type="application/x-wiki" title="Edit this page" href="/w/index.php?title=Hypercholesterolemia&amp;action=edit" />
<link rel="edit" title="Edit this page" href="/w/index.php?title=Hypercholesterolemia&amp;action=edit" />
<link rel="apple-touch-icon" href="/static/apple-touch/wikipedia.png" />
<link rel="shortcut icon" href="/static/favicon/wikipedia.ico" />
<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (en)" />
<link rel="EditURI" type="application/rsd+xml" href="//en.wikipedia.org/w/api.php?action=rsd" />
<link rel="alternate" hreflang="x-default" href="/wiki/Hypercholesterolemia" />
<link rel="copyright" href="//creativecommons.org/licenses/by-sa/3.0/" />
<link rel="alternate" type="application/atom+xml" title="Wikipedia Atom feed" href="/w/index.php?title=Special:RecentChanges&amp;feed=atom" />
<link rel="canonical" href="https://en.wikipedia.org/wiki/Hypercholesterolemia" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.math.styles%7Cext.uls.nojs%7Cext.visualEditor.viewPageTarget.noscript%7Cext.wikihiero%7Cmediawiki.legacy.commonPrint%2Cshared%7Cmediawiki.sectionAnchor%7Cmediawiki.skinning.interface%7Cmediawiki.ui.button%7Cskins.vector.styles%7Cwikibase.client.init&amp;only=styles&amp;skin=vector&amp;*" />
<meta name="ResourceLoaderDynamicStyles" content="" />
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=site&amp;only=styles&amp;skin=vector&amp;*" />
<style>a:lang(ar),a:lang(kk-arab),a:lang(mzn),a:lang(ps),a:lang(ur){text-decoration:none}
/* cache key: global:resourceloader:filter:minify-css:7:de1ab5287c9076b96eedd3f97a84a7b6 */</style>
<script src="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=startup&amp;only=scripts&amp;skin=vector&amp;*"></script>
<script>if(window.mw){
mw.config.set({"wgCanonicalNamespace":"","wgCanonicalSpecialPageName":false,"wgNamespaceNumber":0,"wgPageName":"Hypercholesterolemia","wgTitle":"Hypercholesterolemia","wgCurRevisionId":670339101,"wgRevisionId":670339101,"wgArticleId":513039,"wgIsArticle":true,"wgIsRedirect":false,"wgAction":"view","wgUserName":null,"wgUserGroups":["*"],"wgCategories":["CS1 maint: Explicit use of et al.","Pages containing cite templates with deprecated parameters","Articles with contributors link","Articles that use a Medicine navs subtemplate","Cholesterol and steroid metabolism disorders","Lipid metabolism disorders","Medical conditions related to obesity"],"wgBreakFrames":false,"wgPageContentLanguage":"en","wgPageContentModel":"wikitext","wgSeparatorTransformTable":["",""],"wgDigitTransformTable":["",""],"wgDefaultDateFormat":"dmy","wgMonthNames":["","January","February","March","April","May","June","July","August","September","October","November","December"],"wgMonthNamesShort":["","Jan","Feb","Mar","Apr","May","Jun","Jul","Aug","Sep","Oct","Nov","Dec"],"wgRelevantPageName":"Hypercholesterolemia","wgRelevantArticleId":513039,"wgIsProbablyEditable":true,"wgRestrictionEdit":[],"wgRestrictionMove":[],"wgMediaViewerOnClick":true,"wgMediaViewerEnabledByDefault":true,"wikilove-recipient":"","wikilove-anon":0,"wgPoweredByHHVM":true,"wgWikiEditorEnabledModules":{"toolbar":true,"dialogs":true,"hidesig":true,"preview":false,"publish":false},"wgBetaFeaturesFeatures":[],"wgVisualEditor":{"pageLanguageCode":"en","pageLanguageDir":"ltr","usePageImages":true,"usePageDescriptions":true},"wgGatherShouldShowTutorial":true,"wgGatherPageImageThumbnail":"//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Cholesterol.svg/100px-Cholesterol.svg.png","wgULSAcceptLanguageList":["en-us","en"],"wgULSCurrentAutonym":"English","wgFlaggedRevsParams":{"tags":{"status":{"levels":1,"quality":2,"pristine":3}}},"wgStableRevisionId":null,"wgCategoryTreePageCategoryOptions":"{\"mode\":0,\"hideprefix\":20,\"showcount\":true,\"namespaces\":false}","wgNoticeProject":"wikipedia","wgWikibaseItemId":"Q762713"});
}</script><script>if(window.mw){
mw.loader.implement("user.options",function($,jQuery){mw.user.options.set({"variant":"en"});});
/* cache key: global:resourceloader:filter:minify-js:7:b2706269305541eba923c165462b22c4 */
}</script>
<script>if(window.mw){
mw.loader.implement("user.tokens",function($,jQuery){mw.user.tokens.set({"editToken":"+\\","patrolToken":"+\\","watchToken":"+\\"});});
}</script>
<script>if(window.mw){
mw.loader.load(["mediawiki.page.startup","mediawiki.legacy.wikibits","mediawiki.legacy.ajax","ext.centralauth.centralautologin","mmv.head","ext.imageMetrics.head","ext.visualEditor.viewPageTarget.init","ext.uls.init","ext.uls.interface","ext.centralNotice.bannerController","skins.vector.js"]);
}</script>
<link rel="dns-prefetch" href="//meta.wikimedia.org" />
<!--[if lt IE 7]><style type="text/css">body{behavior:url("/w/static/1.26wmf13/skins/Vector/csshover.min.htc")}</style><![endif]-->
</head>
<body class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Hypercholesterolemia skin-vector action-view">
		<div id="mw-page-base" class="noprint"></div>
		<div id="mw-head-base" class="noprint"></div>
		<div id="content" class="mw-body" role="main">
			<a id="top"></a>

							<div id="siteNotice"><!-- CentralNotice --></div>
						<div class="mw-indicators">
</div>
			<h1 id="firstHeading" class="firstHeading" lang="en">Hypercholesterolemia</h1>
									<div id="bodyContent" class="mw-body-content">
									<div id="siteSub">From Wikipedia, the free encyclopedia</div>
								<div id="contentSub"></div>
												<div id="jump-to-nav" class="mw-jump">
					Jump to:					<a href="#mw-head">navigation</a>, 					<a href="#p-search">search</a>
				</div>
				<div id="mw-content-text" lang="en" dir="ltr" class="mw-content-ltr"><table class="infobox" style="width:22em">
<tr>
<th colspan="2" style="text-align:center;font-size:125%;font-weight:bold;background-color: lightgrey">Hypercholesterolemia</th>
</tr>
<tr>
<td colspan="2" style="text-align:center"><a href="/wiki/File:Cholesterol.svg" class="image"><img alt="Cholesterol.svg" src="//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Cholesterol.svg/230px-Cholesterol.svg.png" width="230" height="155" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Cholesterol.svg/345px-Cholesterol.svg.png 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/9/9a/Cholesterol.svg/460px-Cholesterol.svg.png 2x" data-file-width="440" data-file-height="296" /></a>
<div>Formula structure of <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a></div>
</td>
</tr>
<tr>
<th colspan="2" style="text-align:center">Classification and external resources</th>
</tr>
<tr>
<th scope="row"><a href="/wiki/Specialty_(medicine)" title="Specialty (medicine)">Specialty</a></th>
<td><a href="/wiki/Cardiology" title="Cardiology">Cardiology</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/ICD-10" title="ICD-10">10</a></th>
<td><a rel="nofollow" class="external text" href="http://apps.who.int/classifications/icd10/browse/2015/en#/E78.0">E78.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/International_Statistical_Classification_of_Diseases_and_Related_Health_Problems" title="International Statistical Classification of Diseases and Related Health Problems">ICD</a>-<a href="/wiki/List_of_ICD-9_codes" title="List of ICD-9 codes">9-CM</a></th>
<td><a rel="nofollow" class="external text" href="http://www.icd9data.com/getICD9Code.ashx?icd9=272.0">272.0</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Diseases_Database" title="Diseases Database">DiseasesDB</a></th>
<td><a rel="nofollow" class="external text" href="http://www.diseasesdatabase.com/ddb6226.htm">6226</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/MedlinePlus" title="MedlinePlus">MedlinePlus</a></th>
<td><a rel="nofollow" class="external text" href="http://www.nlm.nih.gov/medlineplus/ency/article/000403.htm">000403</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/EMedicine" title="EMedicine">eMedicine</a></th>
<td><a rel="nofollow" class="external text" href="http://www.emedicine.com/med/topic1073.htm">med/1073</a></td>
</tr>
<tr>
<th scope="row"><a href="/wiki/Medical_Subject_Headings" title="Medical Subject Headings">MeSH</a></th>
<td><a rel="nofollow" class="external text" href="//www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&amp;term=D006937">D006937</a></td>
</tr>
</table>
<p><b>Hypercholesterolemia</b> (<a href="/wiki/American_and_British_English_spelling_differences#Simplification_of_ae_and_oe" title="American and British English spelling differences">also spelled</a> <b>hypercholesterolaemia</b> also called <b>dyslipidemia</b>) is the presence of high levels of <a href="/wiki/Cholesterol" title="Cholesterol">cholesterol</a> in the blood.<sup id="cite_ref-Durrington_1-0" class="reference"><a href="#cite_note-Durrington-1"><span>[</span>1<span>]</span></a></sup> It is a form of "<a href="/wiki/Hyperlipidemia" title="Hyperlipidemia">hyperlipidemia</a>" (elevated levels of <a href="/wiki/Lipid" title="Lipid">lipids</a> in the blood) and "hyperlipoproteinemia" (elevated levels of <a href="/wiki/Lipoprotein" title="Lipoprotein">lipoproteins</a> in the blood).<sup id="cite_ref-Durrington_1-1" class="reference"><a href="#cite_note-Durrington-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Cholesterol is a <a href="/wiki/Sterol" title="Sterol">sterol</a>; see the diagrammatic structure at the right. It is one of three major classes of <a href="/wiki/Lipid" title="Lipid">lipids</a> which all animal cells utilize to construct their membranes and is thus manufactured by all animal cells. Plant cells do not manufacture cholesterol. It is also the precursor of the <a href="/wiki/Steroid_hormone" title="Steroid hormone">steroid hormones</a>, <a href="/wiki/Bile_acid" title="Bile acid">bile acids</a> and <a href="/wiki/Vitamin_D" title="Vitamin D">vitamin D</a>.</p>
<p>Since cholesterol is insoluble in water, it is transported in the blood plasma within protein particles (<a href="/wiki/Lipoproteins" title="Lipoproteins" class="mw-redirect">lipoproteins</a>). Lipoproteins are classified by their density: <a href="/wiki/Very_low_density_lipoprotein" title="Very low density lipoprotein" class="mw-redirect">very low density lipoprotein</a> (VLDL), <a href="/wiki/Low_density_lipoprotein" title="Low density lipoprotein" class="mw-redirect">low density lipoprotein</a> (LDL), <a href="/wiki/Intermediate_density_lipoprotein" title="Intermediate density lipoprotein" class="mw-redirect">intermediate density lipoprotein</a> (IDL) and <a href="/wiki/High_density_lipoprotein" title="High density lipoprotein" class="mw-redirect">high density lipoprotein</a> (HDL).<sup id="cite_ref-2" class="reference"><a href="#cite_note-2"><span>[</span>2<span>]</span></a></sup> All the lipoproteins carry cholesterol, but elevated levels of the lipoproteins other than HDL (termed non-HDL cholesterol), particularly LDL-cholesterol are associated with an increased risk of <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a> and <a href="/wiki/Coronary_heart_disease" title="Coronary heart disease" class="mw-redirect">coronary heart disease</a>.<sup id="cite_ref-3" class="reference"><a href="#cite_note-3"><span>[</span>3<span>]</span></a></sup> In contrast, higher levels of HDL cholesterol are protective.<sup id="cite_ref-4" class="reference"><a href="#cite_note-4"><span>[</span>4<span>]</span></a></sup> Elevated levels of non-HDL cholesterol and LDL in the blood may be a consequence of <a href="/wiki/Diet_(nutrition)" title="Diet (nutrition)">diet</a>, <a href="/wiki/Obesity" title="Obesity">obesity</a>, inherited (genetic) diseases (such as <a href="/wiki/LDL_receptor" title="LDL receptor">LDL receptor</a> mutations in <a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">familial hypercholesterolemia</a>), or the presence of other diseases such as <a href="/wiki/Diabetes_mellitus" title="Diabetes mellitus">diabetes</a> and <a href="/wiki/Hypothyroidism" title="Hypothyroidism">an underactive thyroid</a>.<sup id="cite_ref-Durrington_1-2" class="reference"><a href="#cite_note-Durrington-1"><span>[</span>1<span>]</span></a></sup></p>
<p>Reducing saturated dietary fat is recommended to reduce total blood cholesterol and LDL in adults.<sup id="cite_ref-Hooper_5-0" class="reference"><a href="#cite_note-Hooper-5"><span>[</span>5<span>]</span></a></sup> In people with very high cholesterol (e.g. familial hypercholesterolemia), diet is often insufficient to achieve the desired lowering of LDL and lipid lowering <a href="/wiki/Pharmaceutical_drug" title="Pharmaceutical drug">medications</a> which reduce cholesterol production or absorption are usually required.<sup id="cite_ref-Ito2011_6-0" class="reference"><a href="#cite_note-Ito2011-6"><span>[</span>6<span>]</span></a></sup> If necessary, other treatments such as LDL <a href="/wiki/Apheresis" title="Apheresis">apheresis</a> or even surgery (for particularly severe subtypes of familial hypercholesterolemia) are performed.<sup id="cite_ref-Ito2011_6-1" class="reference"><a href="#cite_note-Ito2011-6"><span>[</span>6<span>]</span></a></sup></p>
<p></p>
<div id="toc" class="toc">
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1 tocsection-1"><a href="#Signs_and_symptoms"><span class="tocnumber">1</span> <span class="toctext">Signs and symptoms</span></a></li>
<li class="toclevel-1 tocsection-2"><a href="#Causes"><span class="tocnumber">2</span> <span class="toctext">Causes</span></a>
<ul>
<li class="toclevel-2 tocsection-3"><a href="#Diet"><span class="tocnumber">2.1</span> <span class="toctext">Diet</span></a></li>
<li class="toclevel-2 tocsection-4"><a href="#Genetics"><span class="tocnumber">2.2</span> <span class="toctext">Genetics</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-5"><a href="#Diagnosis"><span class="tocnumber">3</span> <span class="toctext">Diagnosis</span></a>
<ul>
<li class="toclevel-2 tocsection-6"><a href="#Classification"><span class="tocnumber">3.1</span> <span class="toctext">Classification</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-7"><a href="#Screening"><span class="tocnumber">4</span> <span class="toctext">Screening</span></a></li>
<li class="toclevel-1 tocsection-8"><a href="#Treatment"><span class="tocnumber">5</span> <span class="toctext">Treatment</span></a>
<ul>
<li class="toclevel-2 tocsection-9"><a href="#Lifestyle"><span class="tocnumber">5.1</span> <span class="toctext">Lifestyle</span></a></li>
<li class="toclevel-2 tocsection-10"><a href="#Medication"><span class="tocnumber">5.2</span> <span class="toctext">Medication</span></a></li>
<li class="toclevel-2 tocsection-11"><a href="#Alternative_medicine"><span class="tocnumber">5.3</span> <span class="toctext">Alternative medicine</span></a></li>
</ul>
</li>
<li class="toclevel-1 tocsection-12"><a href="#Epidemiology"><span class="tocnumber">6</span> <span class="toctext">Epidemiology</span></a></li>
<li class="toclevel-1 tocsection-13"><a href="#Research"><span class="tocnumber">7</span> <span class="toctext">Research</span></a></li>
<li class="toclevel-1 tocsection-14"><a href="#Special_populations"><span class="tocnumber">8</span> <span class="toctext">Special populations</span></a></li>
<li class="toclevel-1 tocsection-15"><a href="#References"><span class="tocnumber">9</span> <span class="toctext">References</span></a></li>
</ul>
</div>
<p></p>
<h2><span class="mw-headline" id="Signs_and_symptoms">Signs and symptoms</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=1" title="Edit section: Signs and symptoms">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Xanthelasma_palpebrarum.jpg" class="image"><img alt="" src="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Xanthelasma_palpebrarum.jpg/220px-Xanthelasma_palpebrarum.jpg" width="220" height="146" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/e/e3/Xanthelasma_palpebrarum.jpg/330px-Xanthelasma_palpebrarum.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/e/e3/Xanthelasma_palpebrarum.jpg 2x" data-file-width="425" data-file-height="283" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Xanthelasma_palpebrarum.jpg" class="internal" title="Enlarge"></a></div>
<a href="/wiki/Xanthelasma" title="Xanthelasma">Xanthelasma palpebrarum</a>, yellowish patches consisting of cholesterol deposits above the eyelids. These are more common in people with <a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">familial hypercholesterolemia</a>.</div>
</div>
</div>
<p>Although hypercholesterolemia itself is <a href="/wiki/Asymptomatic" title="Asymptomatic">asymptomatic</a>, longstanding elevation of serum cholesterol can lead to <a href="/wiki/Atherosclerosis" title="Atherosclerosis">atherosclerosis</a>.<sup id="cite_ref-BMJ2008_7-0" class="reference"><a href="#cite_note-BMJ2008-7"><span>[</span>7<span>]</span></a></sup> Over a period of decades, chronically elevated serum cholesterol contributes to formation of <a href="/wiki/Atheroma" title="Atheroma">atheromatous plaques</a> in the arteries. This can lead to progressive <a href="/wiki/Stenosis" title="Stenosis">stenosis</a> (narrowing) or even complete <a href="/wiki/Vascular_occlusion" title="Vascular occlusion">occlusion</a> (blockage) of the involved arteries. Alternatively smaller plaques may rupture and cause a clot to form and obstruct blood flow.<sup id="cite_ref-8" class="reference"><a href="#cite_note-8"><span>[</span>8<span>]</span></a></sup> A sudden occlusion of a coronary artery results in a <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> or heart attack. An occlusion of an artery supplying the brain can cause a <a href="/wiki/Stroke" title="Stroke">stroke</a>. If the development of the stenosis or occlusion is gradual blood supply to the tissues and organs slowly diminishes until organ function becomes impaired. At this point that tissue <a href="/wiki/Ischemia" title="Ischemia">ischemia</a> (restriction in blood supply) may manifest as specific <a href="/wiki/Symptom" title="Symptom">symptoms</a>. For example, temporary ischemia of the brain (commonly referred to as a <a href="/wiki/Transient_ischemic_attack" title="Transient ischemic attack">transient ischemic attack</a>) may manifest as temporary loss of vision, <a href="/wiki/Dizziness" title="Dizziness">dizziness</a> and impairment of <a href="/wiki/Equilibrioception" title="Equilibrioception">balance</a>, <a href="/wiki/Aphasia" title="Aphasia">aphasia</a> (difficulty speaking), <a href="/wiki/Paresis" title="Paresis">paresis</a> (weakness) and <a href="/wiki/Paresthesia" title="Paresthesia">paresthesia</a> (numbness or tingling), usually on one side of the body. Insufficient blood supply to the heart may manifest as <a href="/wiki/Angina_pectoris" title="Angina pectoris">chest pain</a>, and ischemia of the eye may manifest as <a href="/wiki/Amaurosis_fugax" title="Amaurosis fugax">transient visual loss in one eye</a>. Insufficient blood supply to the legs may manifest as <a href="/wiki/Claudication" title="Claudication">calf pain when walking</a>, while in the intestines it may present as <a href="/wiki/Abdominal_angina" title="Abdominal angina">abdominal pain after eating a meal</a>.<sup id="cite_ref-Durrington_1-3" class="reference"><a href="#cite_note-Durrington-1"><span>[</span>1<span>]</span></a></sup><sup id="cite_ref-Grundy1998_9-0" class="reference"><a href="#cite_note-Grundy1998-9"><span>[</span>9<span>]</span></a></sup></p>
<p>Some types of hypercholesterolemia lead to specific physical findings. For example, familial hypercholesterolemia (Type IIa hyperlipoproteinemia) may be associated with <a href="/wiki/Xanthelasma" title="Xanthelasma">xanthelasma palpebrarum</a> (yellowish patches underneath the skin around the eyelids),<sup id="cite_ref-Shields2008_10-0" class="reference"><a href="#cite_note-Shields2008-10"><span>[</span>10<span>]</span></a></sup> <a href="/wiki/Arcus_senilis" title="Arcus senilis">arcus senilis</a> (white or gray discoloration of the peripheral <a href="/wiki/Cornea" title="Cornea">cornea</a>),<sup id="cite_ref-Zech2008_11-0" class="reference"><a href="#cite_note-Zech2008-11"><span>[</span>11<span>]</span></a></sup> and <a href="/wiki/Xanthoma" title="Xanthoma">xanthomata</a> (deposition of yellowish cholesterol-rich material) of the <a href="/wiki/Tendon" title="Tendon">tendons</a>, especially of the fingers.<sup id="cite_ref-Andrews2006_12-0" class="reference"><a href="#cite_note-Andrews2006-12"><span>[</span>12<span>]</span></a></sup><sup id="cite_ref-Rapini2007_13-0" class="reference"><a href="#cite_note-Rapini2007-13"><span>[</span>13<span>]</span></a></sup> Type III hyperlipidemia may be associated with xanthomata of the palms, knees and elbows.<sup id="cite_ref-Andrews2006_12-1" class="reference"><a href="#cite_note-Andrews2006-12"><span>[</span>12<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Causes">Causes</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=2" title="Edit section: Causes">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Hypercholesterolemia is typically due to a combination of environmental and genetic factors.<sup id="cite_ref-BMJ2008_7-1" class="reference"><a href="#cite_note-BMJ2008-7"><span>[</span>7<span>]</span></a></sup> Environmental factors include <a href="/wiki/Obesity" title="Obesity">obesity</a> and <a href="/wiki/Dietary" title="Dietary" class="mw-redirect">dietary</a> choices.<sup id="cite_ref-BMJ2008_7-2" class="reference"><a href="#cite_note-BMJ2008-7"><span>[</span>7<span>]</span></a></sup> Genetic contributions are usually due to the additive effects of multiple genes, though occasionally may be due to a single gene defect such as in the case of <a href="/wiki/Familial_hypercholesterolaemia" title="Familial hypercholesterolaemia" class="mw-redirect">familial hypercholesterolaemia</a>.<sup id="cite_ref-BMJ2008_7-3" class="reference"><a href="#cite_note-BMJ2008-7"><span>[</span>7<span>]</span></a></sup> A number of secondary causes exist including: <a href="/wiki/Diabetes_mellitus_type_2" title="Diabetes mellitus type 2">diabetes mellitus type 2</a>, <a href="/wiki/Obesity" title="Obesity">obesity</a>, <a href="/wiki/Alcohol" title="Alcohol">alcohol</a>, <a href="/wiki/Monoclonal_gammopathy" title="Monoclonal gammopathy">monoclonal gammopathy</a>, <a href="/wiki/Dialysis" title="Dialysis">dialysis</a>, <a href="/wiki/Nephrotic_syndrome" title="Nephrotic syndrome">nephrotic syndrome</a>, <a href="/wiki/Hypothyroidism" title="Hypothyroidism">hypothyroidism</a>, <a href="/wiki/Cushing%E2%80%99s_syndrome" title="Cushing’s syndrome" class="mw-redirect">Cushing’s syndrome</a>, <a href="/wiki/Anorexia_nervosa" title="Anorexia nervosa">anorexia nervosa</a>, medications (<a href="/wiki/Thiazide_diuretics" title="Thiazide diuretics" class="mw-redirect">thiazide diuretics</a>, <a href="/wiki/Ciclosporin" title="Ciclosporin">ciclosporin</a>, <a href="/wiki/Glucocorticoids" title="Glucocorticoids" class="mw-redirect">glucocorticoids</a>, <a href="/wiki/Beta_blockers" title="Beta blockers" class="mw-redirect">beta blockers</a>, <a href="/wiki/Retinoic_acid" title="Retinoic acid">retinoic acid</a>).<sup id="cite_ref-BMJ2008_7-4" class="reference"><a href="#cite_note-BMJ2008-7"><span>[</span>7<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Diet">Diet</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=3" title="Edit section: Diet">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="thumb tright">
<div class="thumbinner" style="width:222px;"><a href="/wiki/File:Lipemic_plasma.jpg" class="image"><img alt="A color photograph of two bags of thawed fresh frozen plasma: The bag on the left was obtained from a donor with hypercholesterolemia, and contains cloudy yellow fluid, while the bag obtained from a normal donor contains clear yellow fluid." src="//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Lipemic_plasma.jpg/220px-Lipemic_plasma.jpg" width="220" height="88" class="thumbimage" srcset="//upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Lipemic_plasma.jpg/330px-Lipemic_plasma.jpg 1.5x, //upload.wikimedia.org/wikipedia/commons/thumb/b/b4/Lipemic_plasma.jpg/440px-Lipemic_plasma.jpg 2x" data-file-width="2330" data-file-height="934" /></a>
<div class="thumbcaption">
<div class="magnify"><a href="/wiki/File:Lipemic_plasma.jpg" class="internal" title="Enlarge"></a></div>
Two bags of <a href="/wiki/Fresh_frozen_plasma" title="Fresh frozen plasma">fresh frozen plasma</a>: The bag on the left was obtained from a <a href="/wiki/Blood_donation" title="Blood donation">donor</a> with <a href="/wiki/Hyperlipidemia" title="Hyperlipidemia">hyperlipidemia</a>, while the other bag was obtained from a donor with normal <a href="/wiki/Blood_lipids" title="Blood lipids">serum lipid</a> levels.</div>
</div>
</div>
<p>Diet has an important effect on blood cholesterol, but the size of this effect varies substantially between individuals.<sup id="cite_ref-14" class="reference"><a href="#cite_note-14"><span>[</span>14<span>]</span></a></sup> About 50% of nonesterified cholesterol is absorbed in the intestine,<sup id="cite_ref-Lichtenstein_15-0" class="reference"><a href="#cite_note-Lichtenstein-15"><span>[</span>15<span>]</span></a></sup> but interindividual variations in the efficiency of uptake, and the effect of other dietary components such as plant sterols and fiber content affect absorption.<sup id="cite_ref-Lichtenstein_15-1" class="reference"><a href="#cite_note-Lichtenstein-15"><span>[</span>15<span>]</span></a></sup> Moreover, when dietary cholesterol intake goes down, production (principally by the liver<sup id="cite_ref-Stryer_16-0" class="reference"><a href="#cite_note-Stryer-16"><span>[</span>16<span>]</span></a></sup>) typically increases, though not always with complete compensation, so that reductions in blood cholesterol can be modest. Reductions in fat intake, particularly saturated fats, also reduce blood cholesterol.<sup id="cite_ref-17" class="reference"><a href="#cite_note-17"><span>[</span>17<span>]</span></a></sup> Dietary sucrose and fructose can raise LDL cholesterol levels in the blood.<sup id="cite_ref-18" class="reference"><a href="#cite_note-18"><span>[</span>18<span>]</span></a></sup> In the United States, the National Lipid Association Expert Panel on Familial Hypercholesterolemia recommends that people with familial hypercholesterolemia restrict intakes of total fat to 25 - 35% of energy intake, saturated fatty acids should make up less than 7% of energy intake, and cholesterol intake should be less than 200&#160;mg per day.<sup id="cite_ref-Ito2011_6-2" class="reference"><a href="#cite_note-Ito2011-6"><span>[</span>6<span>]</span></a></sup> The inclusion of 2 g per day of plant stanol or sterol esters and 10 to 20 g per day of soluble fiber decrease dietary cholesterol absorption.<sup id="cite_ref-Ito2011_6-3" class="reference"><a href="#cite_note-Ito2011-6"><span>[</span>6<span>]</span></a></sup> Dietary changes can typically achieve reductions of 10 to 15% in blood cholesterol.<sup id="cite_ref-Ito2011_6-4" class="reference"><a href="#cite_note-Ito2011-6"><span>[</span>6<span>]</span></a></sup></p>
<p>Maintaining a healthy body weight through increased physical activity and appropriate caloric intake is also important. Overweight or obese individuals can lower blood cholesterol by losing weight - on average a kilogram of weight loss can reduce LDL cholesterol by 0.8&#160;mg/dl.<sup id="cite_ref-Ito2011_6-5" class="reference"><a href="#cite_note-Ito2011-6"><span>[</span>6<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Genetics">Genetics</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=4" title="Edit section: Genetics">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Genetic abnormalities are in some cases completely responsible for hypercholesterolemia, such as in familial hypercholesterolemia, where one or more <a href="/wiki/Genetic_mutation" title="Genetic mutation" class="mw-redirect">genetic mutations</a> in the <a href="/wiki/Autosomal_dominant" title="Autosomal dominant" class="mw-redirect">autosomal dominant</a> <a href="/wiki/APOB" title="APOB" class="mw-redirect">APOB</a> gene exist, the <a href="/wiki/Autosomal_recessive" title="Autosomal recessive" class="mw-redirect">autosomal recessive</a> <i><a href="/wiki/LDLRAP1" title="LDLRAP1" class="mw-redirect">LDLRAP1</a></i> gene, autosomal dominant <a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">familial hypercholesterolemia</a> (<i>HCHOLA3</i>) variant of the <i><a href="/wiki/PCSK9" title="PCSK9">PCSK9</a></i> gene, or the <a href="/wiki/LDLR" title="LDLR" class="mw-redirect">LDL receptor gene</a>.<sup id="cite_ref-ghr_19-0" class="reference"><a href="#cite_note-ghr-19"><span>[</span>19<span>]</span></a></sup></p>
<p>Even when no single mutation is responsible for hypercholesterolemia, genetic predisposition still plays a major role in combination with <a href="/wiki/Sedentary_lifestyle" title="Sedentary lifestyle">sedentary lifestyle</a>, obesity, or an <a href="/w/index.php?title=Atherogenic_diet&amp;action=edit&amp;redlink=1" class="new" title="Atherogenic diet (page does not exist)">atherogenic diet</a>.<sup id="cite_ref-Citko2010_20-0" class="reference"><a href="#cite_note-Citko2010-20"><span>[</span>20<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Diagnosis">Diagnosis</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=5" title="Edit section: Diagnosis">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="hatnote">See also: <a href="/wiki/High-density_lipoprotein#Recommended_ranges" title="High-density lipoprotein">High-density lipoprotein § Recommended ranges</a> and <a href="/wiki/Low-density_lipoprotein#Normal_ranges" title="Low-density lipoprotein">Low-density lipoprotein § Normal ranges</a></div>
<table class="wikitable" style="float:right; width:30em; border:solid 1px #999999; margin:0 0 1em 1em;">
<tr>
<th colspan="4" style="background-color: #CCEEEE;">Interpretation of cholesterol levels</th>
</tr>
<tr>
<th>cholesterol type</th>
<th>mg/dL</th>
<th>mmol/L</th>
<th>interpretation</th>
</tr>
<tr>
<td rowspan="3">total cholesterol</td>
<td>&lt;200</td>
<td>&lt;5.2</td>
<td>desirable<sup id="cite_ref-BBDstatins_21-0" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td>200-239</td>
<td>5.2-6.2</td>
<td>borderline<sup id="cite_ref-BBDstatins_21-1" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td>&gt;240</td>
<td>&gt;6.2</td>
<td>high<sup id="cite_ref-BBDstatins_21-2" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td rowspan="5">LDL cholesterol</td>
<td>&lt;100</td>
<td>&lt;2.6</td>
<td>most desirable<sup id="cite_ref-BBDstatins_21-3" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td>100-129</td>
<td>2.6-3.3</td>
<td>good<sup id="cite_ref-BBDstatins_21-4" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td>130-159</td>
<td>3.4-4.1</td>
<td>borderline high<sup id="cite_ref-BBDstatins_21-5" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td>160-189</td>
<td>4.1-4.9</td>
<td>high and undesirable<sup id="cite_ref-BBDstatins_21-6" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td>&gt;190</td>
<td>&gt;4.9</td>
<td>very high<sup id="cite_ref-BBDstatins_21-7" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td rowspan="5">HDL cholesterol</td>
<td>&lt;40</td>
<td>&lt;1.0</td>
<td>undesirable; risk increased<sup id="cite_ref-BBDstatins_21-8" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td>41-59</td>
<td>1.0-1.5</td>
<td>okay, but not optimal<sup id="cite_ref-BBDstatins_21-9" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
<tr>
<td>&gt;60</td>
<td>&gt;1.55</td>
<td>good; risk lowered<sup id="cite_ref-BBDstatins_21-10" class="reference"><a href="#cite_note-BBDstatins-21"><span>[</span>21<span>]</span></a></sup></td>
</tr>
</table>
<table class="wikitable" style="float:right; width:30em; border:solid 1px #999999; margin:0 0 1em 1em;">
<tr>
<th colspan="4" style="background-color: #CCEEEE;">Indications to lower LDL cholesterol</th>
</tr>
<tr>
<th>Coronary risk</th>
<th>because they have...</th>
<th>should consider</th>
<th>reduction indicated</th>
</tr>
<tr>
<td>high</td>
<td>&gt;20% risk of MI in 10 years, or risk factor such as coronary heart disease, diabetes, peripheral-artery disease, carotid-artery disease, or aortic aneurysm</td>
<td>&gt;70&#160;mg/dL, 3.88&#160;mmol/L especially if there are risk factors<sup id="cite_ref-BBDstatins2_22-0" class="reference"><a href="#cite_note-BBDstatins2-22"><span>[</span>22<span>]</span></a></sup><sup id="cite_ref-23" class="reference"><a href="#cite_note-23"><span>[</span>23<span>]</span></a></sup></td>
<td>&gt;100&#160;mg/dL, 5.55&#160;mmol/L<sup id="cite_ref-BBDstatins2_22-1" class="reference"><a href="#cite_note-BBDstatins2-22"><span>[</span>22<span>]</span></a></sup></td>
</tr>
<tr>
<td>moderately high</td>
<td>10-20% risk of MI in 10 years and &gt; 1 risk factors</td>
<td>&gt;100&#160;mg/dL, 5.55&#160;mmol/L<sup id="cite_ref-BBDstatins2_22-2" class="reference"><a href="#cite_note-BBDstatins2-22"><span>[</span>22<span>]</span></a></sup></td>
<td>&gt;130&#160;mg/dL, 7.21&#160;mmol/L<sup id="cite_ref-BBDstatins2_22-3" class="reference"><a href="#cite_note-BBDstatins2-22"><span>[</span>22<span>]</span></a></sup></td>
</tr>
<tr>
<td>moderate</td>
<td>&lt;10% risk of MI in 10 years &gt; 1 risk factors</td>
<td>&gt;130&#160;mg/dL, 7.21&#160;mmol/L<sup id="cite_ref-BBDstatins2_22-4" class="reference"><a href="#cite_note-BBDstatins2-22"><span>[</span>22<span>]</span></a></sup></td>
<td>&gt;160&#160;mg/dL, 8.88&#160;mmol/L<sup id="cite_ref-BBDstatins2_22-5" class="reference"><a href="#cite_note-BBDstatins2-22"><span>[</span>22<span>]</span></a></sup></td>
</tr>
<tr>
<td>low</td>
<td>No or one risk factor</td>
<td>&gt;160&#160;mg/dL, 8.88&#160;mmol/L<sup id="cite_ref-BBDstatins2_22-6" class="reference"><a href="#cite_note-BBDstatins2-22"><span>[</span>22<span>]</span></a></sup></td>
<td>&gt;190&#160;mg/dL, 10.5&#160;mmol/L<sup id="cite_ref-BBDstatins2_22-7" class="reference"><a href="#cite_note-BBDstatins2-22"><span>[</span>22<span>]</span></a></sup></td>
</tr>
</table>
<p>Cholesterol is measured as milligrams per deciliter (mg/dL) of blood in the United States and some other countries. In the United Kingdom, most European countries, and Canada, millimoles per liter of blood (mmol/Ll) is the measure.<sup id="cite_ref-MayoClinic_24-0" class="reference"><a href="#cite_note-MayoClinic-24"><span>[</span>24<span>]</span></a></sup></p>
<p>For healthy adults, the UK National Health Service recommends upper limits of total cholesterol of 5&#160;mmol/L, and low-density lipoprotein cholesterol (LDL) of 3&#160;mmol/L. For people at high risk of cardiovascular disease, the recommended limit for total cholesterol is 4&#160;mmol/L, and 2&#160;mmol/L for LDL.<sup id="cite_ref-NHScholesterol_25-0" class="reference"><a href="#cite_note-NHScholesterol-25"><span>[</span>25<span>]</span></a></sup></p>
<p>In the United States, the National Heart, Lung, and Blood Institute within the National Institutes of Health classifies total cholesterol of less than 200&#160;mg/dL as “desirable,” 200 to 239&#160;mg/dL as “borderline high,” and 240&#160;mg/dL or more as “high”.<sup id="cite_ref-NHLBIcholesterol_26-0" class="reference"><a href="#cite_note-NHLBIcholesterol-26"><span>[</span>26<span>]</span></a></sup></p>
<p>No absolute cutoff between normal and abnormal cholesterol levels exists, and interpretation of values must be made in relation to other health conditions and risk factors.</p>
<p>Higher levels of total cholesterol increase the risk of cardiovascular disease, particularly coronary heart disease. Levels of LDL or non-HDL cholesterol both predict future coronary heart disease; which is the better predictor is disputed.<sup id="cite_ref-ESC_2011_27-0" class="reference"><a href="#cite_note-ESC_2011-27"><span>[</span>27<span>]</span></a></sup> High levels of small dense LDL may be particularly adverse, although measurement of small dense LDL is not advocated for risk prediction.<sup id="cite_ref-ESC_2011_27-1" class="reference"><a href="#cite_note-ESC_2011-27"><span>[</span>27<span>]</span></a></sup> In the past, LDL and VLDL levels were rarely measured directly due to cost. Levels of fasting <a href="/wiki/Triglyceride" title="Triglyceride">triglycerides</a> were taken as an indicator of VLDL levels (generally about 45% of fasting triglycerides is composed of VLDL), while LDL was usually estimated by the Friedewald formula:</p>
<p>LDL <img class="mwe-math-fallback-image-inline tex" alt="\approx" src="//upload.wikimedia.org/math/3/0/a/30a83899d43b156384be84db854210fd.png" /> total cholesterol - HDL - (0.2 x fasting triglycerides).</p>
<p>However, this equation is not valid on nonfasting blood samples or if fasting triglycerides are elevated &gt;4.5&#160;mmol/L (&gt; ∼400&#160;mg/dL). Recent guidelines have, therefore, advocated the use of direct methods for measurement of LDL wherever possible.<sup id="cite_ref-ESC_2011_27-2" class="reference"><a href="#cite_note-ESC_2011-27"><span>[</span>27<span>]</span></a></sup> It may be useful to measure all lipoprotein subfractions ( <a href="/wiki/Very-low-density_lipoprotein" title="Very-low-density lipoprotein" class="mw-redirect">VLDL</a>, <a href="/wiki/Intermediate_density_lipoprotein" title="Intermediate density lipoprotein" class="mw-redirect">IDL</a>, <a href="/wiki/Low-density_lipoprotein" title="Low-density lipoprotein">LDL</a>, and <a href="/wiki/High-density_lipoprotein" title="High-density lipoprotein">HDL</a>) when assessing hypercholesterolemia and measurement of <a href="/wiki/Apolipoproteins" title="Apolipoproteins" class="mw-redirect">apolipoproteins</a> and <a href="/wiki/Lipoprotein_(a)" title="Lipoprotein (a)" class="mw-redirect">lipoprotein (a)</a> can also be of value.<sup id="cite_ref-ESC_2011_27-3" class="reference"><a href="#cite_note-ESC_2011-27"><span>[</span>27<span>]</span></a></sup> Genetic screening is now advised if a form of familial hypercholesterolemia is suspected.<sup id="cite_ref-ESC_2011_27-4" class="reference"><a href="#cite_note-ESC_2011-27"><span>[</span>27<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Classification">Classification</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=6" title="Edit section: Classification">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<div class="hatnote relarticle mainarticle">Main article: <a href="/wiki/Hyperlipidemia" title="Hyperlipidemia">Hyperlipidemia</a></div>
<p>Classically, hypercholesterolemia was categorized by lipoprotein <a href="/wiki/Electrophoresis" title="Electrophoresis">electrophoresis</a> and the <a href="/wiki/Hyperlipidemia#Classification" title="Hyperlipidemia">Fredrickson classification</a>. Newer methods, such as "lipoprotein subclass analysis", have offered significant improvements in understanding the connection with atherosclerosis progression and clinical consequences. If the hypercholesterolemia is hereditary (<a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">familial hypercholesterolemia</a>), more often a <a href="/wiki/Family_history_(medicine)" title="Family history (medicine)">family history</a> of premature, earlier onset atherosclerosis is found.</p>
<h2><span class="mw-headline" id="Screening">Screening</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=7" title="Edit section: Screening">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>The <a href="/wiki/U.S._Preventive_Services_Task_Force" title="U.S. Preventive Services Task Force" class="mw-redirect">U.S. Preventive Services Task Force</a> strongly recommends routine screening for men 35 years and older and women 45 years and older for lipid disorders and the treatment of abnormal lipids in people who are at increased risk of coronary heart disease. They also recommend routinely screening men aged 20 to 35 years and women aged 20 to 45 years if they have other risk factors for <a href="/wiki/Coronary_heart_disease" title="Coronary heart disease" class="mw-redirect">coronary heart disease</a>.<sup id="cite_ref-Pignone_28-0" class="reference"><a href="#cite_note-Pignone-28"><span>[</span>28<span>]</span></a></sup> In Canada, screening is recommended for men 40 and older and women 50 and older.<sup id="cite_ref-29" class="reference"><a href="#cite_note-29"><span>[</span>29<span>]</span></a></sup> In those with normal cholesterol levels, screening is recommended once every five years.<sup id="cite_ref-30" class="reference"><a href="#cite_note-30"><span>[</span>30<span>]</span></a></sup> Once people are on a statin further testing provides little benefit except to possibly determine compliance with treatment.<sup id="cite_ref-31" class="reference"><a href="#cite_note-31"><span>[</span>31<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Treatment">Treatment</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=8" title="Edit section: Treatment">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Recommendations for both <a href="/wiki/Primary_prevention" title="Primary prevention" class="mw-redirect">primary prevention</a><sup id="cite_ref-pmid16620402_32-0" class="reference"><a href="#cite_note-pmid16620402-32"><span>[</span>32<span>]</span></a></sup> and <a href="/wiki/Secondary_prevention" title="Secondary prevention" class="mw-redirect">secondary prevention</a><sup id="cite_ref-pmid16973010_33-0" class="reference"><a href="#cite_note-pmid16973010-33"><span>[</span>33<span>]</span></a></sup> have been published. For those at high risk, a combination of lifestyle modification and <a href="/wiki/Statins" title="Statins" class="mw-redirect">statins</a> has been shown to decrease mortality.<sup id="cite_ref-BMJ2008_7-5" class="reference"><a href="#cite_note-BMJ2008-7"><span>[</span>7<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Lifestyle">Lifestyle</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=9" title="Edit section: Lifestyle">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>Lifestyle changes recommended for those with high cholesterol include: smoking cessation, limiting alcohol consumption, increasing physical activity, and maintaining a healthy weight. A diet that emphasizes low-cholesterol foods, restricts <a href="/wiki/Saturated_fats" title="Saturated fats" class="mw-redirect">saturated fats</a>,<sup id="cite_ref-BMJ2008_7-6" class="reference"><a href="#cite_note-BMJ2008-7"><span>[</span>7<span>]</span></a></sup> and avoids <i>trans</i> fat is also recommended.<sup id="cite_ref-urlHow_Can_I_Lower_High_Cholesterol.3F_34-0" class="reference"><a href="#cite_note-urlHow_Can_I_Lower_High_Cholesterol.3F-34"><span>[</span>34<span>]</span></a></sup> In strictly controlled surroundings, dietary changes can reduce cholesterol levels by 15%. In practice, dietary advice can provide a modest decrease in cholesterol levels and may be sufficient in the treatment of mildly elevated cholesterol.<sup id="cite_ref-Tang1998_35-0" class="reference"><a href="#cite_note-Tang1998-35"><span>[</span>35<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Medication">Medication</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=10" title="Edit section: Medication">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p><a href="/wiki/Statins" title="Statins" class="mw-redirect">Statins</a> (or HMG-CoA reductase inhibitors) are commonly used to treat hypercholesterolemia if diet is ineffective. Other agents that may be used include: <a href="/wiki/Fibrate" title="Fibrate">fibrates</a>, <a href="/wiki/Nicotinic_acid" title="Nicotinic acid" class="mw-redirect">nicotinic acid</a>, and <a href="/wiki/Cholestyramine" title="Cholestyramine">cholestyramine</a>.<sup id="cite_ref-NICE67_36-0" class="reference"><a href="#cite_note-NICE67-36"><span>[</span>36<span>]</span></a></sup> These, however, are only recommended if statins are not tolerated or in pregnant women.<sup id="cite_ref-NICE67_36-1" class="reference"><a href="#cite_note-NICE67-36"><span>[</span>36<span>]</span></a></sup> Statins can reduce total cholesterol by about 50% in the majority of people;<sup id="cite_ref-ESC_2011_27-5" class="reference"><a href="#cite_note-ESC_2011-27"><span>[</span>27<span>]</span></a></sup> effects appear similar regardless of the statin used.<sup id="cite_ref-CMAJ11_37-0" class="reference"><a href="#cite_note-CMAJ11-37"><span>[</span>37<span>]</span></a></sup> While statins are effective in decreasing mortality in those who have had previous <a href="/wiki/Cardiovascular_disease" title="Cardiovascular disease">cardiovascular disease</a>, debate exists over whether or not they are effective in those with high cholesterol but no other health problems.<sup id="cite_ref-AIM2010_38-0" class="reference"><a href="#cite_note-AIM2010-38"><span>[</span>38<span>]</span></a></sup> One review did not find a mortality benefit in those at high risk, but without prior cardiovascular disease.<sup id="cite_ref-AIM2010_38-1" class="reference"><a href="#cite_note-AIM2010-38"><span>[</span>38<span>]</span></a></sup> Other reviews concluded a mortality benefit does exist,<sup id="cite_ref-CMAJ11_37-1" class="reference"><a href="#cite_note-CMAJ11-37"><span>[</span>37<span>]</span></a></sup><sup id="cite_ref-39" class="reference"><a href="#cite_note-39"><span>[</span>39<span>]</span></a></sup><sup id="cite_ref-40" class="reference"><a href="#cite_note-40"><span>[</span>40<span>]</span></a></sup> but concerns regarding the quality of the evidence persist.<sup id="cite_ref-Cochrane11_41-0" class="reference"><a href="#cite_note-Cochrane11-41"><span>[</span>41<span>]</span></a></sup> Statins may improve <a href="/wiki/Quality_of_life" title="Quality of life">quality of life</a> when used in people without existing cardiovascular disease (i.e. for primary prevention).<sup id="cite_ref-42" class="reference"><a href="#cite_note-42"><span>[</span>42<span>]</span></a></sup> Statins decrease cholesterol in children with hypercholesterolemia, but no studies as of 2010 show improved clinical outcomes<sup id="cite_ref-Leben2010_43-0" class="reference"><a href="#cite_note-Leben2010-43"><span>[</span>43<span>]</span></a></sup> and diet is the mainstay of therapy in childhood.<sup id="cite_ref-ESC_2011_27-6" class="reference"><a href="#cite_note-ESC_2011-27"><span>[</span>27<span>]</span></a></sup> Injectable antibodies against the protein <a href="/wiki/PCSK9" title="PCSK9">PCSK9</a> (<a href="/wiki/Evolocumab" title="Evolocumab">evolocumab</a>, <a href="/wiki/Bococizumab" title="Bococizumab">bococizumab</a>, <a href="/wiki/Alirocumab" title="Alirocumab">alirocumab</a>) can reduce LDL cholesterol and have been shown to reduce mortality.<sup id="cite_ref-Navarese2015_44-0" class="reference"><a href="#cite_note-Navarese2015-44"><span>[</span>44<span>]</span></a></sup></p>
<h3><span class="mw-headline" id="Alternative_medicine">Alternative medicine</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=11" title="Edit section: Alternative medicine">edit</a><span class="mw-editsection-bracket">]</span></span></h3>
<p>According to a survey in 2002, <a href="/wiki/Alternative_medicine" title="Alternative medicine">alternative medicine</a> was used in an attempt to treat cholesterol by 1.1% of U.S. adults. Consistent with previous surveys, this one found the majority of individuals (55%) used it in conjunction with <a href="/wiki/Conventional_medicine" title="Conventional medicine" class="mw-redirect">conventional medicine</a>.<sup id="cite_ref-NCCIH_45-0" class="reference"><a href="#cite_note-NCCIH-45"><span>[</span>45<span>]</span></a></sup> A review of trials of <a href="/wiki/Phytosterols" title="Phytosterols" class="mw-redirect">phytosterols</a> and/or phytostanols reported an average of 9% lowering of LDL-cholesterol.<sup id="cite_ref-PMID1909_46-0" class="reference"><a href="#cite_note-PMID1909-46"><span>[</span>46<span>]</span></a></sup> In 2000, the Food and Drug Administration approved the labeling of foods containing specified amounts of phytosterol esters or phytostanol esters as cholesterol-lowering; in 2003, an FDA Interim Health Claim Rule extended that label claim to foods or dietary supplements delivering more than 0.8&#160;g/day of phytosterols or phytostanols. Some researchers, however, are concerned about diet supplementation with plant sterol esters and draw attention to lack of long-term safety data.<sup id="cite_ref-Wein2009_47-0" class="reference"><a href="#cite_note-Wein2009-47"><span>[</span>47<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Epidemiology">Epidemiology</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=12" title="Edit section: Epidemiology">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Rates of high total cholesterol in the United States in 2010 are just over 13%, down from 17% in 2000.<sup id="cite_ref-48" class="reference"><a href="#cite_note-48"><span>[</span>48<span>]</span></a></sup></p>
<p>Average total cholesterol in the United Kingdom is 5.9&#160;mmol/L, while in rural China and Japan, average total cholesterol is 4&#160;mmol/L.<sup id="cite_ref-BMJ2008_7-7" class="reference"><a href="#cite_note-BMJ2008-7"><span>[</span>7<span>]</span></a></sup> Rates of coronary artery disease are high in Great Britain, but low in rural China and Japan.<sup id="cite_ref-BMJ2008_7-8" class="reference"><a href="#cite_note-BMJ2008-7"><span>[</span>7<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Research">Research</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=13" title="Edit section: Research">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Various clinical practice guidelines have addressed the treatment of hypercholesterolemia.</p>
<p>The <a href="/wiki/National_Cholesterol_Education_Program" title="National Cholesterol Education Program">National Cholesterol Education Program</a> revised their guidelines;<sup id="cite_ref-pmid15358046_49-0" class="reference"><a href="#cite_note-pmid15358046-49"><span>[</span>49<span>]</span></a></sup> however, their 2004 revisions have been criticized for use of nonrandomized, observational data.<sup id="cite_ref-pmid17015870_50-0" class="reference"><a href="#cite_note-pmid17015870-50"><span>[</span>50<span>]</span></a></sup></p>
<p>In the UK, the <a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence" class="mw-redirect">National Institute for Health and Clinical Excellence</a> has made recommendations for the treatment of elevated cholesterol levels, published in 2008.<sup id="cite_ref-NICE67_36-2" class="reference"><a href="#cite_note-NICE67-36"><span>[</span>36<span>]</span></a></sup></p>
<p>The Task Force for the management of dyslipidaemias of the European Society of Cardiology and the European Atherosclerosis Society published guidelines for the management of dyslipidaemias in 2011.<sup id="cite_ref-ESC_2011_27-7" class="reference"><a href="#cite_note-ESC_2011-27"><span>[</span>27<span>]</span></a></sup></p>
<h2><span class="mw-headline" id="Special_populations">Special populations</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=14" title="Edit section: Special populations">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<p>Among people whose <a href="/wiki/Life_expectancy" title="Life expectancy">life expectancy</a> is relatively short, hypercholesterolemia is not a risk factor for death by any cause including <a href="/wiki/Coronary_heart_disease" title="Coronary heart disease" class="mw-redirect">coronary heart disease</a>.<sup id="cite_ref-AMDAten_51-0" class="reference"><a href="#cite_note-AMDAten-51"><span>[</span>51<span>]</span></a></sup> Among people older than 70, hypercholesterolemia is not a risk factor for being hospitalized with <a href="/wiki/Myocardial_infarction" title="Myocardial infarction">myocardial infarction</a> or <a href="/wiki/Angina" title="Angina" class="mw-redirect">angina</a>.<sup id="cite_ref-AMDAten_51-1" class="reference"><a href="#cite_note-AMDAten-51"><span>[</span>51<span>]</span></a></sup> There are also increased risks in people older than 85 in the use of <a href="/wiki/Statin" title="Statin">statin</a> drugs.<sup id="cite_ref-AMDAten_51-2" class="reference"><a href="#cite_note-AMDAten-51"><span>[</span>51<span>]</span></a></sup> Because of this, medications which lower lipid levels should not be routinely used among people with limited life expectancy.<sup id="cite_ref-AMDAten_51-3" class="reference"><a href="#cite_note-AMDAten-51"><span>[</span>51<span>]</span></a></sup></p>
<p>The <a href="/wiki/American_College_of_Physicians" title="American College of Physicians">American College of Physicians</a> recommends for hypercholesterolemia in people with <a href="/wiki/Diabetes" title="Diabetes" class="mw-redirect">diabetes</a>:<sup id="cite_ref-pmid15096336_52-0" class="reference"><a href="#cite_note-pmid15096336-52"><span>[</span>52<span>]</span></a></sup></p>
<ol>
<li>Lipid-lowering therapy should be used for secondary prevention of cardiovascular mortality and morbidity for all adults with known coronary artery disease and type 2 diabetes.</li>
<li>Statins should be used for primary prevention against macrovascular complications in adults with type 2 diabetes and other cardiovascular risk factors.</li>
<li>Once lipid-lowering therapy is initiated, people with type 2 diabetes mellitus should be taking at least moderate doses of a statin<sup id="cite_ref-pmid15096337_53-0" class="reference"><a href="#cite_note-pmid15096337-53"><span>[</span>53<span>]</span></a></sup></li>
<li>For those people with type 2 diabetes who are taking statins, routine monitoring of liver function tests or muscle enzymes is not recommended except in specific circumstances.</li>
</ol>
<h2><span class="mw-headline" id="References">References</span><span class="mw-editsection"><span class="mw-editsection-bracket">[</span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit&amp;section=15" title="Edit section: References">edit</a><span class="mw-editsection-bracket">]</span></span></h2>
<div class="reflist columns references-column-count references-column-count-2" style="-moz-column-count: 2; -webkit-column-count: 2; column-count: 2; list-style-type: decimal;">
<ol class="references">
<li id="cite_note-Durrington-1"><span class="mw-cite-backlink">^ <a href="#cite_ref-Durrington_1-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Durrington_1-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Durrington_1-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Durrington_1-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Durrington, P (August 2003). "Dyslipidaemia". <i><a href="/wiki/The_Lancet" title="The Lancet">The Lancet</a></i> <b>362</b> (9385): 717–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2803%2914234-1">10.1016/S0140-6736(03)14234-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12957096">12957096</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Dyslipidaemia&amp;rft.au=Durrington%2C+P&amp;rft.aufirst=P&amp;rft.aulast=Durrington&amp;rft.date=August+2003&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2803%2914234-1&amp;rft_id=info%3Apmid%2F12957096&amp;rft.issue=9385&amp;rft.jtitle=The+Lancet&amp;rft.pages=717-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=362" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-2"><span class="mw-cite-backlink"><b><a href="#cite_ref-2">^</a></b></span> <span class="reference-text"><span class="citation journal">Biggerstaff KD, Wooten JS (December 2004). "Understanding lipoproteins as transporters of cholesterol and other lipids". <i>Adv Physiol Educ</i> <b>28</b> (1–4): 105–6. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1152%2Fadvan.00048.2003">10.1152/advan.00048.2003</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15319192">15319192</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Understanding+lipoproteins+as+transporters+of+cholesterol+and+other+lipids&amp;rft.au=Biggerstaff+KD%2C+Wooten+JS&amp;rft.aulast=Biggerstaff+KD%2C+Wooten+JS&amp;rft.date=December+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1152%2Fadvan.00048.2003&amp;rft_id=info%3Apmid%2F15319192&amp;rft.issue=1%E2%80%934&amp;rft.jtitle=Adv+Physiol+Educ&amp;rft.pages=105-6&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=28" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-3"><span class="mw-cite-backlink"><b><a href="#cite_ref-3">^</a></b></span> <span class="reference-text"><span class="citation journal">Carmena R, Duriez P, Fruchart JC (June 2004). "Atherogenic lipoprotein particles in atherosclerosis". <i>Circulation</i> <b>109</b> (23 Suppl 1): III2–7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2F01.CIR.0000131511.50734.44">10.1161/01.CIR.0000131511.50734.44</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15198959">15198959</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Atherogenic+lipoprotein+particles+in+atherosclerosis&amp;rft.au=Carmena+R%2C+Duriez+P%2C+Fruchart+JC&amp;rft.aulast=Carmena+R%2C+Duriez+P%2C+Fruchart+JC&amp;rft.date=June+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2F01.CIR.0000131511.50734.44&amp;rft_id=info%3Apmid%2F15198959&amp;rft.issue=23+Suppl+1&amp;rft.jtitle=Circulation&amp;rft.pages=III2-7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=109" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-4"><span class="mw-cite-backlink"><b><a href="#cite_ref-4">^</a></b></span> <span class="reference-text"><span class="citation journal">Kontush A, Chapman MJ (March 2006). "Antiatherogenic small, dense HDL--guardian angel of the arterial wall?". <i>Nat Clin Pract Cardiovasc Med</i> <b>3</b> (3): 144–53. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1038%2Fncpcardio0500">10.1038/ncpcardio0500</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16505860">16505860</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Antiatherogenic+small%2C+dense+HDL--guardian+angel+of+the+arterial+wall%3F&amp;rft.au=Kontush+A%2C+Chapman+MJ&amp;rft.aulast=Kontush+A%2C+Chapman+MJ&amp;rft.date=March+2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1038%2Fncpcardio0500&amp;rft_id=info%3Apmid%2F16505860&amp;rft.issue=3&amp;rft.jtitle=Nat+Clin+Pract+Cardiovasc+Med&amp;rft.pages=144-53&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=3" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Hooper-5"><span class="mw-cite-backlink"><b><a href="#cite_ref-Hooper_5-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hooper L, Summerbell CD, Thompson R et al. (2012). Hooper, Lee, ed. "Reduced or modified dietary fat for preventing cardiovascular disease". <i>Cochrane Database Syst Rev</i> <b>5</b>: CD002137. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD002137.pub3">10.1002/14651858.CD002137.pub3</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/22592684">22592684</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Reduced+or+modified+dietary+fat+for+preventing+cardiovascular+disease&amp;rft.au=Hooper+L%2C+Summerbell+CD%2C+Thompson+R&amp;rft.aulast=Hooper+L%2C+Summerbell+CD%2C+Thompson+R&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD002137.pub3&amp;rft_id=info%3Apmid%2F22592684&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.pages=CD002137&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Ito2011-6"><span class="mw-cite-backlink">^ <a href="#cite_ref-Ito2011_6-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Ito2011_6-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-Ito2011_6-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-Ito2011_6-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-Ito2011_6-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-Ito2011_6-5"><sup><i><b>f</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ito MK, McGowan MP, Moriarty PM (June 2011). "Management of familial hypercholesterolemias in adult patients: recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia". <i>J Clin Lipidol</i> <b>5</b> (3 Suppl): S38–45. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jacl.2011.04.001">10.1016/j.jacl.2011.04.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21600528">21600528</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Management+of+familial+hypercholesterolemias+in+adult+patients%3A+recommendations+from+the+National+Lipid+Association+Expert+Panel+on+Familial+Hypercholesterolemia&amp;rft.au=Ito+MK%2C+McGowan+MP%2C+Moriarty+PM&amp;rft.aulast=Ito+MK%2C+McGowan+MP%2C+Moriarty+PM&amp;rft.date=June+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jacl.2011.04.001&amp;rft_id=info%3Apmid%2F21600528&amp;rft.issue=3+Suppl&amp;rft.jtitle=J+Clin+Lipidol&amp;rft.pages=S38-45&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=5" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-BMJ2008-7"><span class="mw-cite-backlink">^ <a href="#cite_ref-BMJ2008_7-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BMJ2008_7-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BMJ2008_7-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-BMJ2008_7-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-BMJ2008_7-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-BMJ2008_7-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-BMJ2008_7-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-BMJ2008_7-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-BMJ2008_7-8"><sup><i><b>i</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Bhatnagar D, Soran H, Durrington PN (2008). "Hypercholesterolaemia and its management". <i>BMJ</i> <b>337</b>: a993. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbmj.a993">10.1136/bmj.a993</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18719012">18719012</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Hypercholesterolaemia+and+its+management&amp;rft.au=Bhatnagar+D%2C+Soran+H%2C+Durrington+PN&amp;rft.aulast=Bhatnagar+D%2C+Soran+H%2C+Durrington+PN&amp;rft.date=2008&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.a993&amp;rft_id=info%3Apmid%2F18719012&amp;rft.jtitle=BMJ&amp;rft.pages=a993&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=337" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-8"><span class="mw-cite-backlink"><b><a href="#cite_ref-8">^</a></b></span> <span class="reference-text"><span class="citation journal">Finn AV, Nakano M, Narula J, Kolodgie FD, Virmani R (July 2010). "Concept of vulnerable/unstable plaque". <i>Arterioscler. Thromb. Vasc. Biol.</i> <b>30</b> (7): 1282–92. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2FATVBAHA.108.179739">10.1161/ATVBAHA.108.179739</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20554950">20554950</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Concept+of+vulnerable%2Funstable+plaque&amp;rft.au=Finn+AV%2C+Nakano+M%2C+Narula+J%2C+Kolodgie+FD%2C+Virmani+R&amp;rft.aulast=Finn+AV%2C+Nakano+M%2C+Narula+J%2C+Kolodgie+FD%2C+Virmani+R&amp;rft.date=July+2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2FATVBAHA.108.179739&amp;rft_id=info%3Apmid%2F20554950&amp;rft.issue=7&amp;rft.jtitle=Arterioscler.+Thromb.+Vasc.+Biol.&amp;rft.pages=1282-92&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Grundy1998-9"><span class="mw-cite-backlink"><b><a href="#cite_ref-Grundy1998_9-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Grundy, SM; Balady, GJ; Criqui, MH; Fletcher, G; Greenland, P; Hiratzka, LF; Houston-Miller, N; Kris-Etherton, P; Krumholz, HM; Larosa, J.; Ockene, I. S.; Pearson, T. A.; Reed, J.; Washington, R.; Smith, S. C. (1998). <a rel="nofollow" class="external text" href="http://circ.ahajournals.org/cgi/content/full/97/18/1876">"Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association"</a>. <i><a href="/wiki/Circulation_(journal)" title="Circulation (journal)">Circulation</a></i> <b>97</b> (18): 1876–87. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2F01.CIR.97.18.1876">10.1161/01.CIR.97.18.1876</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9603549">9603549</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Primary+prevention+of+coronary+heart+disease%3A+guidance+from+Framingham%3A+a+statement+for+healthcare+professionals+from+the+AHA+Task+Force+on+Risk+Reduction.+American+Heart+Association&amp;rft.au=Balady%2C+GJ&amp;rft.au=Criqui%2C+MH&amp;rft.aufirst=SM&amp;rft.au=Fletcher%2C+G&amp;rft.au=Greenland%2C+P&amp;rft.au=Grundy%2C+SM&amp;rft.au=Hiratzka%2C+LF&amp;rft.au=Houston-Miller%2C+N&amp;rft.au=Kris-Etherton%2C+P&amp;rft.au=Krumholz%2C+HM&amp;rft.au=Larosa%2C+J.&amp;rft.aulast=Grundy&amp;rft.au=Ockene%2C+I.+S.&amp;rft.au=Pearson%2C+T.+A.&amp;rft.au=Reed%2C+J.&amp;rft.au=Smith%2C+S.+C.&amp;rft.au=Washington%2C+R.&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcgi%2Fcontent%2Ffull%2F97%2F18%2F1876&amp;rft_id=info%3Adoi%2F10.1161%2F01.CIR.97.18.1876&amp;rft_id=info%3Apmid%2F9603549&amp;rft.issue=18&amp;rft.jtitle=Circulation&amp;rft.pages=1876-87&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=97" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Shields2008-10"><span class="mw-cite-backlink"><b><a href="#cite_ref-Shields2008_10-0">^</a></b></span> <span class="reference-text"><span class="citation book">Shields, C; Shields, J (2008). <i>Eyelid, conjunctival, and orbital tumors: atlas and textbook</i>. Hagerstown, Maryland: Lippincott Williams &amp; Wilkins. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7817-7578-7" title="Special:BookSources/0-7817-7578-7">0-7817-7578-7</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.aufirst=C&amp;rft.aulast=Shields&amp;rft.au=Shields%2C+C&amp;rft.au=Shields%2C+J&amp;rft.btitle=Eyelid%2C+conjunctival%2C+and+orbital+tumors%3A+atlas+and+textbook&amp;rft.date=2008&amp;rft.genre=book&amp;rft.isbn=0-7817-7578-7&amp;rft.place=Hagerstown%2C+Maryland&amp;rft.pub=Lippincott+Williams+%26+Wilkins&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Zech2008-11"><span class="mw-cite-backlink"><b><a href="#cite_ref-Zech2008_11-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Zech LA Jr, Hoeg JM (2008-03-10). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2279133">"Correlating corneal arcus with atherosclerosis in familial hypercholesterolemia"</a>. <i>Lipids Health Dis</i> <b>7</b> (1): 7. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1186%2F1476-511X-7-7">10.1186/1476-511X-7-7</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2279133">2279133</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/18331643">18331643</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Correlating+corneal+arcus+with+atherosclerosis+in+familial+hypercholesterolemia&amp;rft.aulast=Zech+LA+Jr%2C+Hoeg+JM&amp;rft.au=Zech+LA+Jr%2C+Hoeg+JM&amp;rft.date=2008-03-10&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2279133&amp;rft_id=info%3Adoi%2F10.1186%2F1476-511X-7-7&amp;rft_id=info%3Apmc%2F2279133&amp;rft_id=info%3Apmid%2F18331643&amp;rft.issue=1&amp;rft.jtitle=Lipids+Health+Dis&amp;rft.pages=7&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=7" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Andrews2006-12"><span class="mw-cite-backlink">^ <a href="#cite_ref-Andrews2006_12-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Andrews2006_12-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation book">James, WD; Berger, TG (2006). <i>Andrews' Diseases of the Skin: Clinical Dermatology</i>. Saunders Elsevier. pp.&#160;530–2. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7216-2921-0" title="Special:BookSources/0-7216-2921-0">0-7216-2921-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.au=Berger%2C+TG&amp;rft.aufirst=WD&amp;rft.au=James%2C+WD&amp;rft.aulast=James&amp;rft.btitle=Andrews%27+Diseases+of+the+Skin%3A+Clinical+Dermatology&amp;rft.date=2006&amp;rft.genre=book&amp;rft.isbn=0-7216-2921-0&amp;rft.pages=530-2&amp;rft.pub=Saunders+Elsevier&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Rapini2007-13"><span class="mw-cite-backlink"><b><a href="#cite_ref-Rapini2007_13-0">^</a></b></span> <span class="reference-text"><span class="citation book">Rapini, RP; Bolognia, JL; Jorizzo, JL (2007). <i>Dermatology: 2-Volume Set</i>. St. Louis, Missouri: Mosby. pp.&#160;1415–6. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/1-4160-2999-0" title="Special:BookSources/1-4160-2999-0">1-4160-2999-0</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.au=Bolognia%2C+JL&amp;rft.aufirst=RP&amp;rft.au=Jorizzo%2C+JL&amp;rft.aulast=Rapini&amp;rft.au=Rapini%2C+RP&amp;rft.btitle=Dermatology%3A+2-Volume+Set&amp;rft.date=2007&amp;rft.genre=book&amp;rft.isbn=1-4160-2999-0&amp;rft.pages=1415-6&amp;rft.place=St.+Louis%2C+Missouri&amp;rft.pub=Mosby&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-14"><span class="mw-cite-backlink"><b><a href="#cite_ref-14">^</a></b></span> <span class="reference-text"><span class="citation journal">Howell WH, McNamara DJ, Tosca MA, Smith BT, Gaines JA (June 1997). "Plasma lipid and lipoprotein responses to dietary fat and cholesterol: a meta-analysis". <i>Am. J. Clin. Nutr.</i> <b>65</b> (6): 1747–64. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9174470">9174470</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Plasma+lipid+and+lipoprotein+responses+to+dietary+fat+and+cholesterol%3A+a+meta-analysis&amp;rft.au=Howell+WH%2C+McNamara+DJ%2C+Tosca+MA%2C+Smith+BT%2C+Gaines+JA&amp;rft.aulast=Howell+WH%2C+McNamara+DJ%2C+Tosca+MA%2C+Smith+BT%2C+Gaines+JA&amp;rft.date=June+1997&amp;rft.genre=article&amp;rft_id=info%3Apmid%2F9174470&amp;rft.issue=6&amp;rft.jtitle=Am.+J.+Clin.+Nutr.&amp;rft.pages=1747-64&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=65" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Lichtenstein-15"><span class="mw-cite-backlink">^ <a href="#cite_ref-Lichtenstein_15-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-Lichtenstein_15-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal"><a href="/wiki/Alice_H._Lichtenstein" title="Alice H. Lichtenstein">Lichtenstein AH</a> (February 1990). "Intestinal cholesterol metabolism". <i>Ann. Med.</i> <b>22</b> (1): 49–52. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3109%2F07853899009147241">10.3109/07853899009147241</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/2184845">2184845</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Intestinal+cholesterol+metabolism&amp;rft.aulast=Lichtenstein+AH&amp;rft.au=Lichtenstein+AH&amp;rft.date=February+1990&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3109%2F07853899009147241&amp;rft_id=info%3Apmid%2F2184845&amp;rft.issue=1&amp;rft.jtitle=Ann.+Med.&amp;rft.pages=49-52&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=22" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Stryer-16"><span class="mw-cite-backlink"><b><a href="#cite_ref-Stryer_16-0">^</a></b></span> <span class="reference-text"><span class="citation book">Stryer, Lubert; Berg, Jeremy Mark; Tymoczko, John L. (2007). <i>Biochemistry</i>. San Francisco: W.H. Freeman. <a href="/wiki/International_Standard_Book_Number" title="International Standard Book Number">ISBN</a>&#160;<a href="/wiki/Special:BookSources/0-7167-8724-5" title="Special:BookSources/0-7167-8724-5">0-7167-8724-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.aulast=Stryer%2C+Lubert%3B+Berg%2C+Jeremy+Mark%3B+Tymoczko%2C+John+L.&amp;rft.au=Stryer%2C+Lubert%3B+Berg%2C+Jeremy+Mark%3B+Tymoczko%2C+John+L.&amp;rft.btitle=Biochemistry&amp;rft.date=2007&amp;rft.genre=book&amp;rft.isbn=0-7167-8724-5&amp;rft.place=San+Francisco&amp;rft.pub=W.H.+Freeman&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-17"><span class="mw-cite-backlink"><b><a href="#cite_ref-17">^</a></b></span> <span class="reference-text"><span class="citation journal">Sacks FM, Katan M (December 2002). "Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease". <i>Am. J. Med</i>. 113 Suppl 9B (9): 13S–24S. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fs0002-9343%2801%2900987-1">10.1016/s0002-9343(01)00987-1</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12566134">12566134</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Randomized+clinical+trials+on+the+effects+of+dietary+fat+and+carbohydrate+on+plasma+lipoproteins+and+cardiovascular+disease&amp;rft.aulast=Sacks+FM%2C+Katan+M&amp;rft.au=Sacks+FM%2C+Katan+M&amp;rft.date=December+2002&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fs0002-9343%2801%2900987-1&amp;rft_id=info%3Apmid%2F12566134&amp;rft.issue=9&amp;rft.jtitle=Am.+J.+Med.&amp;rft.pages=13S-24S&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=113+Suppl+9B" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-18"><span class="mw-cite-backlink"><b><a href="#cite_ref-18">^</a></b></span> <span class="reference-text"><span class="citation journal">Schaefer, EJ; Gleason, JA; Dansinger, ML (June 2009). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2682989">"Dietary fructose and glucose differentially affect lipid and glucose homeostasis"</a>. <i>The Journal of nutrition</i> <b>139</b> (6): 1257S–1262S. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3945%2Fjn.108.098186">10.3945/jn.108.098186</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2682989">2682989</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19403705">19403705</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Dietary+fructose+and+glucose+differentially+affect+lipid+and+glucose+homeostasis&amp;rft.au=Dansinger%2C+ML&amp;rft.aufirst=EJ&amp;rft.au=Gleason%2C+JA&amp;rft.aulast=Schaefer&amp;rft.au=Schaefer%2C+EJ&amp;rft.date=June+2009&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2682989&amp;rft_id=info%3Adoi%2F10.3945%2Fjn.108.098186&amp;rft_id=info%3Apmc%2F2682989&amp;rft_id=info%3Apmid%2F19403705&amp;rft.issue=6&amp;rft.jtitle=The+Journal+of+nutrition&amp;rft.pages=1257S-1262S&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=139" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-ghr-19"><span class="mw-cite-backlink"><b><a href="#cite_ref-ghr_19-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://ghr.nlm.nih.gov/condition=hypercholesterolemia">"Hypercholesterolemia"</a>. <i>Genetics Home Reference</i>. U.S. National Institutes of Health<span class="reference-accessdate">. Retrieved <span class="nowrap">5 December</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Hypercholesterolemia&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fghr.nlm.nih.gov%2Fcondition%3Dhypercholesterolemia&amp;rft.jtitle=Genetics+Home+Reference&amp;rft.pub=U.S.+National+Institutes+of+Health&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Citko2010-20"><span class="mw-cite-backlink"><b><a href="#cite_ref-Citko2010_20-0">^</a></b></span> <span class="reference-text"><span class="citation web">Citkowitz E, Isley WL (2010). <a rel="nofollow" class="external text" href="http://emedicine.medscape.com/article/121424-overview">"Polygenic Hypercholesterolemia"</a>. <i>eMedicine</i>. <a href="/wiki/Medscape" title="Medscape">Medscape</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Polygenic+Hypercholesterolemia&amp;rft.au=Citkowitz+E%2C+Isley+WL&amp;rft.aulast=Citkowitz+E%2C+Isley+WL&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Femedicine.medscape.com%2Farticle%2F121424-overview&amp;rft.jtitle=eMedicine&amp;rft.pub=Medscape&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-BBDstatins-21"><span class="mw-cite-backlink">^ <a href="#cite_ref-BBDstatins_21-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BBDstatins_21-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BBDstatins_21-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-BBDstatins_21-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-BBDstatins_21-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-BBDstatins_21-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-BBDstatins_21-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-BBDstatins_21-7"><sup><i><b>h</b></i></sup></a> <a href="#cite_ref-BBDstatins_21-8"><sup><i><b>i</b></i></sup></a> <a href="#cite_ref-BBDstatins_21-9"><sup><i><b>j</b></i></sup></a> <a href="#cite_ref-BBDstatins_21-10"><sup><i><b>k</b></i></sup></a></span> <span class="reference-text"><span class="citation journal"><a href="/wiki/Consumer_Reports" title="Consumer Reports">Consumer Reports</a>; <a href="/wiki/Drug_Effectiveness_Review_Project" title="Drug Effectiveness Review Project">Drug Effectiveness Review Project</a> (March 2013). <a rel="nofollow" class="external text" href="http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/StatinsUpdate-FINAL.pdf">"Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price"</a> <span style="font-size:85%;">(PDF)</span>. <i>Best Buy Drugs</i> (Consumer Reports): 9<span class="reference-accessdate">. Retrieved <span class="nowrap">27 March</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Evaluating+statin+drugs+to+treat+High+Cholesterol+and+Heart+Disease%3A+Comparing+Effectiveness%2C+Safety%2C+and+Price&amp;rft.au=Consumer+Reports&amp;rft.au=Drug+Effectiveness+Review+Project&amp;rft.aulast=Consumer+Reports&amp;rft.date=March+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.consumerreports.org%2Fhealth%2Fresources%2Fpdf%2Fbest-buy-drugs%2FStatinsUpdate-FINAL.pdf&amp;rft.jtitle=Best+Buy+Drugs&amp;rft.pages=9&amp;rft.pub=Consumer+Reports&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span>, which cites</span>
<ul>
<li><span class="citation web"><a href="/wiki/United_States_Department_of_Health_and_Human_Services" title="United States Department of Health and Human Services">United States Department of Health and Human Services</a>; <a href="/wiki/National_Heart,_Lung,_and_Blood_Institute" title="National Heart, Lung, and Blood Institute">National Heart, Lung, and Blood Institute</a>; <a href="/wiki/National_Institutes_of_Health" title="National Institutes of Health">National Institutes of Health</a> (June 2005). <a rel="nofollow" class="external text" href="http://www.nhlbi.nih.gov/health/public/heart/chol/wyntk.htm">"NHLBI, High Blood Cholesterol: What You Need to Know"</a>. <i>nhlbi.nih.gov</i><span class="reference-accessdate">. Retrieved <span class="nowrap">27 March</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=NHLBI%2C+High+Blood+Cholesterol%3A+What+You+Need+to+Know&amp;rft.aulast=United+States+Department+of+Health+and+Human+Services&amp;rft.au=National+Heart%2C+Lung%2C+and+Blood+Institute&amp;rft.au=National+Institutes+of+Health&amp;rft.au=United+States+Department+of+Health+and+Human+Services&amp;rft.date=June+2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.nhlbi.nih.gov%2Fhealth%2Fpublic%2Fheart%2Fchol%2Fwyntk.htm&amp;rft.jtitle=nhlbi.nih.gov&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></li>
</ul>
</li>
<li id="cite_note-BBDstatins2-22"><span class="mw-cite-backlink">^ <a href="#cite_ref-BBDstatins2_22-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-BBDstatins2_22-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-BBDstatins2_22-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-BBDstatins2_22-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-BBDstatins2_22-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-BBDstatins2_22-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-BBDstatins2_22-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-BBDstatins2_22-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal"><a href="/wiki/Consumer_Reports" title="Consumer Reports">Consumer Reports</a>; <a href="/wiki/Drug_Effectiveness_Review_Project" title="Drug Effectiveness Review Project">Drug Effectiveness Review Project</a> (March 2013). <a rel="nofollow" class="external text" href="http://www.consumerreports.org/health/resources/pdf/best-buy-drugs/StatinsUpdate-FINAL.pdf">"Evaluating statin drugs to treat High Cholesterol and Heart Disease: Comparing Effectiveness, Safety, and Price"</a> <span style="font-size:85%;">(PDF)</span>. <i>Best Buy Drugs</i> (Consumer Reports): 9<span class="reference-accessdate">. Retrieved <span class="nowrap">27 March</span> 2013</span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Evaluating+statin+drugs+to+treat+High+Cholesterol+and+Heart+Disease%3A+Comparing+Effectiveness%2C+Safety%2C+and+Price&amp;rft.au=Consumer+Reports&amp;rft.au=Drug+Effectiveness+Review+Project&amp;rft.aulast=Consumer+Reports&amp;rft.date=March+2013&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.consumerreports.org%2Fhealth%2Fresources%2Fpdf%2Fbest-buy-drugs%2FStatinsUpdate-FINAL.pdf&amp;rft.jtitle=Best+Buy+Drugs&amp;rft.pages=9&amp;rft.pub=Consumer+Reports&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-23"><span class="mw-cite-backlink"><b><a href="#cite_ref-23">^</a></b></span> <span class="reference-text"><span class="citation journal">Grundy, SM; Cleeman, JI; Merz, CN; Brewer HB, Jr; Clark, LT; Hunninghake, DB; Pasternak, RC; Smith SC, Jr; Stone, NJ; National Heart, Lung, and Blood, Institute; American College of Cardiology, Foundation; American Heart, Association (Jul 13, 2004). "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.". <i>Circulation</i> <b>110</b> (2): 227–39. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1161%2F01.cir.0000133317.49796.0e">10.1161/01.cir.0000133317.49796.0e</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15249516">15249516</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Implications+of+recent+clinical+trials+for+the+National+Cholesterol+Education+Program+Adult+Treatment+Panel+III+guidelines.&amp;rft.aufirst=SM&amp;rft.au=Grundy%2C+SM&amp;rft.aulast=Grundy&amp;rft.date=Jul+13%2C+2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1161%2F01.cir.0000133317.49796.0e&amp;rft_id=info%3Apmid%2F15249516&amp;rft.issue=2&amp;rft.jtitle=Circulation&amp;rft.pages=227-39&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=110" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameter <code style="color:inherit; border:inherit; padding:inherit;">|coauthors=</code> (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-MayoClinic-24"><span class="mw-cite-backlink"><b><a href="#cite_ref-MayoClinic_24-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.mayoclinic.com/health/high-blood-cholesterol/DS00178/DSECTION=tests-and-diagnosis">High Cholesterol – Tests and Diagnosis</a>, Mayo Clinic staff. Retrieved 2013-03-09.</span></li>
<li id="cite_note-NHScholesterol-25"><span class="mw-cite-backlink"><b><a href="#cite_ref-NHScholesterol_25-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.nhs.uk/Conditions/Cholesterol/Pages/Diagnosis.aspx">Diagnosing High Cholesterol</a>, NHS Choices. Retrieved 2013-03-09.</span></li>
<li id="cite_note-NHLBIcholesterol-26"><span class="mw-cite-backlink"><b><a href="#cite_ref-NHLBIcholesterol_26-0">^</a></b></span> <span class="reference-text"><a rel="nofollow" class="external text" href="http://www.nhlbi.nih.gov/guidelines/cholesterol/atglance.pdf">ATP III Guidelines At-A-Glance Quick Desk Reference</a>, National Cholesterol Education Program. Retrieved 2013-03-09.</span></li>
<li id="cite_note-ESC_2011-27"><span class="mw-cite-backlink">^ <a href="#cite_ref-ESC_2011_27-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-ESC_2011_27-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-ESC_2011_27-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-ESC_2011_27-3"><sup><i><b>d</b></i></sup></a> <a href="#cite_ref-ESC_2011_27-4"><sup><i><b>e</b></i></sup></a> <a href="#cite_ref-ESC_2011_27-5"><sup><i><b>f</b></i></sup></a> <a href="#cite_ref-ESC_2011_27-6"><sup><i><b>g</b></i></sup></a> <a href="#cite_ref-ESC_2011_27-7"><sup><i><b>h</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Reiner Z, Catapano AL, De Backer G et al. (July 2011). "ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)". <i>Eur. Heart J.</i> <b>32</b> (14): 1769–818. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Feurheartj%2Fehr158">10.1093/eurheartj/ehr158</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21712404">21712404</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=ESC%2FEAS+Guidelines+for+the+management+of+dyslipidaemias%3A+the+Task+Force+for+the+management+of+dyslipidaemias+of+the+European+Society+of+Cardiology+%28ESC%29+and+the+European+Atherosclerosis+Society+%28EAS%29&amp;rft.aulast=Reiner+Z%2C+Catapano+AL%2C+De+Backer+G&amp;rft.au=Reiner+Z%2C+Catapano+AL%2C+De+Backer+G&amp;rft.date=July+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Feurheartj%2Fehr158&amp;rft_id=info%3Apmid%2F21712404&amp;rft.issue=14&amp;rft.jtitle=Eur.+Heart+J.&amp;rft.pages=1769-818&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=32" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-Pignone-28"><span class="mw-cite-backlink"><b><a href="#cite_ref-Pignone_28-0">^</a></b></span> <span class="reference-text"><span class="citation web">U.S. Preventive Services Task Force. <a rel="nofollow" class="external text" href="http://www.uspreventiveservicestaskforce.org/uspstf/uspschol.htm">"Screening for Lipid Disorders: Recommendations and Rationale"</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.aulast=U.S.+Preventive+Services+Task+Force&amp;rft.au=U.S.+Preventive+Services+Task+Force&amp;rft.btitle=Screening+for+Lipid+Disorders%3A+Recommendations+and+Rationale&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fuspstf%2Fuspschol.htm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-29"><span class="mw-cite-backlink"><b><a href="#cite_ref-29">^</a></b></span> <span class="reference-text"><span class="citation journal">Genest, J; Frohlich, J, Fodor, G, McPherson, R, Working Group on Hypercholesterolemia and Other, Dyslipidemias (2003-10-28). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC219626">"Recommendations for the management of dyslipidemia and the prevention of cardiovascular disease: summary of the 2003 update"</a>. <i>Canadian Medical Association Journal</i> <b>169</b> (9): 921–4. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC219626">219626</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/14581310">14581310</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Recommendations+for+the+management+of+dyslipidemia+and+the+prevention+of+cardiovascular+disease%3A+summary+of+the+2003+update&amp;rft.aufirst=J&amp;rft.au=Genest%2C+J&amp;rft.aulast=Genest&amp;rft.date=2003-10-28&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC219626&amp;rft_id=info%3Apmc%2F219626&amp;rft_id=info%3Apmid%2F14581310&amp;rft.issue=9&amp;rft.jtitle=Canadian+Medical+Association+Journal&amp;rft.pages=921-4&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=169" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameter <code style="color:inherit; border:inherit; padding:inherit;">|coauthors=</code> (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-30"><span class="mw-cite-backlink"><b><a href="#cite_ref-30">^</a></b></span> <span class="reference-text"><span class="citation journal">National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel, III) (2002-12-17). <a rel="nofollow" class="external text" href="http://circ.ahajournals.org/content/106/25/3143.full.pdf+html">"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report"</a> <span style="font-size:85%;">(PDF)</span>. <i>Circulation</i> <b>106</b> (25): 3143–421. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/12485966">12485966</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Third+Report+of+the+National+Cholesterol+Education+Program+%28NCEP%29+Expert+Panel+on+Detection%2C+Evaluation%2C+and+Treatment+of+High+Blood+Cholesterol+in+Adults+%28Adult+Treatment+Panel+III%29+final+report&amp;rft.aufirst=III%29&amp;rft.aulast=National+Cholesterol+Education+Program+%28NCEP%29+Expert+Panel+on+Detection%2C+Evaluation%2C+and+Treatment+of+High+Blood+Cholesterol+in+Adults+%28Adult+Treatment+Panel&amp;rft.au=National+Cholesterol+Education+Program+%28NCEP%29+Expert+Panel+on+Detection%2C+Evaluation%2C+and+Treatment+of+High+Blood+Cholesterol+in+Adults+%28Adult+Treatment+Panel%2C+III%29&amp;rft.date=2002-12-17&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fcirc.ahajournals.org%2Fcontent%2F106%2F25%2F3143.full.pdf%2Bhtml&amp;rft_id=info%3Apmid%2F12485966&amp;rft.issue=25&amp;rft.jtitle=Circulation&amp;rft.pages=3143-421&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=106" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-31"><span class="mw-cite-backlink"><b><a href="#cite_ref-31">^</a></b></span> <span class="reference-text"><span class="citation journal">Spector, R; Snapinn, SM (2011). "Statins for secondary prevention of cardiovascular disease: the right dose". <i>Pharmacology</i> <b>87</b> (1–2): 63–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1159%2F000322999">10.1159/000322999</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21228612">21228612</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Statins+for+secondary+prevention+of+cardiovascular+disease%3A+the+right+dose&amp;rft.aufirst=R&amp;rft.aulast=Spector&amp;rft.au=Snapinn%2C+SM&amp;rft.au=Spector%2C+R&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1159%2F000322999&amp;rft_id=info%3Apmid%2F21228612&amp;rft.issue=1%E2%80%932&amp;rft.jtitle=Pharmacology&amp;rft.pages=63-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=87" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16620402-32"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16620402_32-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Pignone, M (2005). <a rel="nofollow" class="external text" href="http://clinicalevidence.com/ceweb/conditions/cvd/0215/0215.jsp">"Primary prevention: dyslipidaemia"</a>. <i>Clin Evid</i> (14): 142–50. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16620402">16620402</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Primary+prevention%3A+dyslipidaemia&amp;rft.aufirst=M&amp;rft.aulast=Pignone&amp;rft.au=Pignone%2C+M&amp;rft.date=2005&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fclinicalevidence.com%2Fceweb%2Fconditions%2Fcvd%2F0215%2F0215.jsp&amp;rft_id=info%3Apmid%2F16620402&amp;rft.issue=14&amp;rft.jtitle=Clin+Evid&amp;rft.pages=142-50&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid16973010-33"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid16973010_33-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Gami, A (2006). <a rel="nofollow" class="external text" href="http://clinicalevidence.com/ceweb/conditions/cvd/0206/0206_guidelines.jsp">"Secondary prevention of ischaemic cardiac events"</a>. <i>Clin Evid</i> (15): 195–228. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/16973010">16973010</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Secondary+prevention+of+ischaemic+cardiac+events&amp;rft.aufirst=A&amp;rft.au=Gami%2C+A&amp;rft.aulast=Gami&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fclinicalevidence.com%2Fceweb%2Fconditions%2Fcvd%2F0206%2F0206_guidelines.jsp&amp;rft_id=info%3Apmid%2F16973010&amp;rft.issue=15&amp;rft.jtitle=Clin+Evid&amp;rft.pages=195-228&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-urlHow_Can_I_Lower_High_Cholesterol.3F-34"><span class="mw-cite-backlink"><b><a href="#cite_ref-urlHow_Can_I_Lower_High_Cholesterol.3F_34-0">^</a></b></span> <span class="reference-text"><span class="citation web"><a rel="nofollow" class="external text" href="http://www.heart.org/idc/groups/heart-public/@wcm/@hcm/documents/downloadable/ucm_300460.pdf">"How Can I Lower High Cholesterol"</a> <span style="font-size:85%;">(PDF)</span>. American Heart Association<span class="reference-accessdate">. Retrieved <span class="nowrap">2011-04-03</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.btitle=How+Can+I+Lower+High+Cholesterol&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.heart.org%2Fidc%2Fgroups%2Fheart-public%2F%40wcm%2F%40hcm%2Fdocuments%2Fdownloadable%2Fucm_300460.pdf&amp;rft.pub=American+Heart+Association&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Tang1998-35"><span class="mw-cite-backlink"><b><a href="#cite_ref-Tang1998_35-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Tang JL, Armitage JM, Lancaster T, Silagy CA, Fowler GH, Neil HA (1998). <a rel="nofollow" class="external text" href="http://www.bmj.com/cgi/content/abstract/316/7139/1213">"Systematic review of dietary intervention trials to lower blood total cholesterol in free-living subjects"</a>. <i>BMJ</i> <b>316</b> (7139): 1213–20. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fbmj.316.7139.1213">10.1136/bmj.316.7139.1213</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC28525">28525</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/9552999">9552999</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Systematic+review+of+dietary+intervention+trials+to+lower+blood+total+cholesterol+in+free-living+subjects&amp;rft.aulast=Tang+JL%2C+Armitage+JM%2C+Lancaster+T%2C+Silagy+CA%2C+Fowler+GH%2C+Neil+HA&amp;rft.au=Tang+JL%2C+Armitage+JM%2C+Lancaster+T%2C+Silagy+CA%2C+Fowler+GH%2C+Neil+HA&amp;rft.date=1998&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.bmj.com%2Fcgi%2Fcontent%2Fabstract%2F316%2F7139%2F1213&amp;rft_id=info%3Adoi%2F10.1136%2Fbmj.316.7139.1213&amp;rft_id=info%3Apmc%2F28525&amp;rft_id=info%3Apmid%2F9552999&amp;rft.issue=7139&amp;rft.jtitle=BMJ&amp;rft.pages=1213-20&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=316" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NICE67-36"><span class="mw-cite-backlink">^ <a href="#cite_ref-NICE67_36-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-NICE67_36-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-NICE67_36-2"><sup><i><b>c</b></i></sup></a></span> <span class="reference-text"><a href="/wiki/National_Institute_for_Health_and_Clinical_Excellence" title="National Institute for Health and Clinical Excellence" class="mw-redirect">National Institute for Health and Clinical Excellence</a>. <i><a rel="nofollow" class="external text" href="http://guidance.nice.org.uk/CG67">Clinical guideline 67: Lipid modification</a></i>. London, 2008.</span></li>
<li id="cite_note-CMAJ11-37"><span class="mw-cite-backlink">^ <a href="#cite_ref-CMAJ11_37-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-CMAJ11_37-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Tonelli, M; Lloyd, A, Clement, F, Conly, J, Husereau, D, Hemmelgarn, B, Klarenbach, S, McAlister, FA, Wiebe, N, Manns, B, for the Alberta Kidney Disease, Network (2011-11-08). <a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447">"Efficacy of statins for primary prevention in people at low cardiovascular risk: a meta-analysis"</a>. <i>CMAJ&#160;: Canadian Medical Association</i> <b>183</b> (16): E1189–E1202. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1503%2Fcmaj.101280">10.1503/cmaj.101280</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC3216447">3216447</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21989464">21989464</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Efficacy+of+statins+for+primary+prevention+in+people+at+low+cardiovascular+risk%3A+a+meta-analysis&amp;rft.aufirst=M&amp;rft.aulast=Tonelli&amp;rft.au=Tonelli%2C+M&amp;rft.date=2011-11-08&amp;rft.genre=article&amp;rft_id=%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC3216447&amp;rft_id=info%3Adoi%2F10.1503%2Fcmaj.101280&amp;rft_id=info%3Apmc%2F3216447&amp;rft_id=info%3Apmid%2F21989464&amp;rft.issue=16&amp;rft.jtitle=CMAJ+%3A+Canadian+Medical+Association&amp;rft.pages=E1189-E1202&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=183" class="Z3988"><span style="display:none;">&#160;</span></span> <span style="display:none;font-size:100%" class="error citation-comment">Cite uses deprecated parameter <code style="color:inherit; border:inherit; padding:inherit;">|coauthors=</code> (<a href="/wiki/Help:CS1_errors#deprecated_params" title="Help:CS1 errors">help</a>)</span></span></li>
<li id="cite_note-AIM2010-38"><span class="mw-cite-backlink">^ <a href="#cite_ref-AIM2010_38-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AIM2010_38-1"><sup><i><b>b</b></i></sup></a></span> <span class="reference-text"><span class="citation journal">Ray; Seshasai, S. R. K.; Erqou, S.; Sever, P.; Jukema, J. W.; Ford, I.; Sattar, N. et al. (2010). <a rel="nofollow" class="external text" href="http://archinte.ama-assn.org/cgi/content/full/170/12/1024">"Statins and All-Cause Mortality in High-Risk Primary Prevention: A Meta-analysis of 11 Randomized Controlled Trials Involving 65 229 Participants"</a>. <i>Arch Intern Med</i> <b>170</b> (12): 1024–31. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1001%2Farchinternmed.2010.182">10.1001/archinternmed.2010.182</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20585067">20585067</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Statins+and+All-Cause+Mortality+in+High-Risk+Primary+Prevention%3A+A+Meta-analysis+of+11+Randomized+Controlled+Trials+Involving+65+229+Participants&amp;rft.au=Erqou%2C+S.&amp;rft.au=Ford%2C+I.&amp;rft.au=Jukema%2C+J.+W.&amp;rft.aulast=Ray&amp;rft.au=Ray&amp;rft.au=Sattar%2C+N.&amp;rft.au=Seshasai%2C+S.+R.+K.&amp;rft.au=Sever%2C+P.&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Farchinte.ama-assn.org%2Fcgi%2Fcontent%2Ffull%2F170%2F12%2F1024&amp;rft_id=info%3Adoi%2F10.1001%2Farchinternmed.2010.182&amp;rft_id=info%3Apmid%2F20585067&amp;rft.issue=12&amp;rft.jtitle=Arch+Intern+Med&amp;rft.pages=1024-31&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=170" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-39"><span class="mw-cite-backlink"><b><a href="#cite_ref-39">^</a></b></span> <span class="reference-text"><span class="citation journal">Mills, EJ; Wu, P; Chong, G; Ghement, I; Singh, S; Akl, EA; Eyawo, O; Guyatt, G; Berwanger, O; Briel, M (February 2011). "Efficacy and safety of statin treatment for cardiovascular disease: a network meta-analysis of 170,255 patients from 76 randomized trials". <i>QJM&#160;: monthly journal of the Association of Physicians</i> <b>104</b> (2): 109–24. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Fqjmed%2Fhcq165">10.1093/qjmed/hcq165</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20934984">20934984</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Efficacy+and+safety+of+statin+treatment+for+cardiovascular+disease%3A+a+network+meta-analysis+of+170%2C255+patients+from+76+randomized+trials&amp;rft.au=Akl%2C+EA&amp;rft.au=Berwanger%2C+O&amp;rft.au=Briel%2C+M&amp;rft.au=Chong%2C+G&amp;rft.au=Eyawo%2C+O&amp;rft.aufirst=EJ&amp;rft.au=Ghement%2C+I&amp;rft.au=Guyatt%2C+G&amp;rft.aulast=Mills&amp;rft.au=Mills%2C+EJ&amp;rft.au=Singh%2C+S&amp;rft.au=Wu%2C+P&amp;rft.date=February+2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1093%2Fqjmed%2Fhcq165&amp;rft_id=info%3Apmid%2F20934984&amp;rft.issue=2&amp;rft.jtitle=QJM+%3A+monthly+journal+of+the+Association+of+Physicians&amp;rft.pages=109-24&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=104" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-40"><span class="mw-cite-backlink"><b><a href="#cite_ref-40">^</a></b></span> <span class="reference-text"><span class="citation journal">Cholesterol Treatment Trialists' (CTT) Collaborators (2012). "The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials". <i>Lancet</i>. Online first (9841): 581–590. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2FS0140-6736%2812%2960367-5">10.1016/S0140-6736(12)60367-5</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=The+effects+of+lowering+LDL+cholesterol+with+statin+therapy+in+people+at+low+risk+of+vascular+disease%3A+meta-analysis+of+individual+data+from+27+randomised+trials&amp;rft.au=Cholesterol+Treatment+Trialists%27+%28CTT%29+Collaborators&amp;rft.aulast=Cholesterol+Treatment+Trialists%27+%28CTT%29+Collaborators&amp;rft.date=2012&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2FS0140-6736%2812%2960367-5&amp;rft.issue=9841&amp;rft.jtitle=Lancet&amp;rft.pages=581-590&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=Online+first" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Cochrane11-41"><span class="mw-cite-backlink"><b><a href="#cite_ref-Cochrane11_41-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Taylor F, Ward K, Moore TH et al. (2011). Taylor, Fiona, ed. "Statins for the primary prevention of cardiovascular disease". <i>Cochrane Database Syst Rev</i> (1): CD004816. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD004816.pub4">10.1002/14651858.CD004816.pub4</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/21249663">21249663</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Statins+for+the+primary+prevention+of+cardiovascular+disease&amp;rft.aulast=Taylor+F%2C+Ward+K%2C+Moore+TH&amp;rft.au=Taylor+F%2C+Ward+K%2C+Moore+TH&amp;rft.date=2011&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004816.pub4&amp;rft_id=info%3Apmid%2F21249663&amp;rft.issue=1&amp;rft.jtitle=Cochrane+Database+Syst+Rev&amp;rft.pages=CD004816&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-42"><span class="mw-cite-backlink"><b><a href="#cite_ref-42">^</a></b></span> <span class="reference-text"><span class="citation journal">Taylor, F; Huffman, MD; Macedo, AF; Moore, TH; Burke, M; Davey Smith, G; Ward, K; Ebrahim, S (31 January 2013). "Statins for the primary prevention of cardiovascular disease.". <i>The Cochrane database of systematic reviews</i> <b>1</b>: CD004816. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1002%2F14651858.CD004816.pub5">10.1002/14651858.CD004816.pub5</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/23440795">23440795</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Statins+for+the+primary+prevention+of+cardiovascular+disease.&amp;rft.au=Burke%2C+M&amp;rft.au=Davey+Smith%2C+G&amp;rft.au=Ebrahim%2C+S&amp;rft.aufirst=F&amp;rft.au=Huffman%2C+MD&amp;rft.aulast=Taylor&amp;rft.au=Macedo%2C+AF&amp;rft.au=Moore%2C+TH&amp;rft.au=Taylor%2C+F&amp;rft.au=Ward%2C+K&amp;rft.date=31+January+2013&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1002%2F14651858.CD004816.pub5&amp;rft_id=info%3Apmid%2F23440795&amp;rft.jtitle=The+Cochrane+database+of+systematic+reviews&amp;rft.pages=CD004816&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=1" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Leben2010-43"><span class="mw-cite-backlink"><b><a href="#cite_ref-Leben2010_43-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Lebenthal Y, Horvath A, Dziechciarz P, Szajewska H, Shamir R (2010). "Are treatment targets for hypercholesterolemia evidence based? Systematic review and meta-analysis of randomised controlled trials". <i>Arch Dis Child</i> <b>95</b> (9): 673–80. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1136%2Fadc.2008.157024">10.1136/adc.2008.157024</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/20515970">20515970</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Are+treatment+targets+for+hypercholesterolemia+evidence+based%3F+Systematic+review+and+meta-analysis+of+randomised+controlled+trials&amp;rft.aulast=Lebenthal+Y%2C+Horvath+A%2C+Dziechciarz+P%2C+Szajewska+H%2C+Shamir+R&amp;rft.au=Lebenthal+Y%2C+Horvath+A%2C+Dziechciarz+P%2C+Szajewska+H%2C+Shamir+R&amp;rft.date=2010&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1136%2Fadc.2008.157024&amp;rft_id=info%3Apmid%2F20515970&amp;rft.issue=9&amp;rft.jtitle=Arch+Dis+Child&amp;rft.pages=673-80&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=95" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Navarese2015-44"><span class="mw-cite-backlink"><b><a href="#cite_ref-Navarese2015_44-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Navarese EP, Kolodziejczak M, Schulze V, Gurbel PA, Tantry U, Lin Y, Brockmeyer M, Kandzari DE, Kubica JM, D'Agostino RB Sr, Kubica J, Volpe M, Agewall S, Kereiakes DJ, Kelm M. (7 July 2015). <a rel="nofollow" class="external text" href="http://annals.org/article.aspx?articleID=2279798">"Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Antibodies in Adults With Hypercholesterolemia: A Systematic Review and Meta-analysis."</a>. <i>Ann Intern Med</i> <b>163</b> (1): 40–51. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2FM14-2957">10.7326/M14-2957</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/25915661">25915661</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Effects+of+Proprotein+Convertase+Subtilisin%2FKexin+Type+9+Antibodies+in+Adults+With+Hypercholesterolemia%3A+A+Systematic+Review+and+Meta-analysis.&amp;rft.aulast=Navarese+EP%2C+Kolodziejczak+M%2C+Schulze+V%2C+Gurbel+PA%2C+Tantry+U%2C+Lin+Y%2C+Brockmeyer+M%2C+Kandzari+DE%2C+Kubica+JM%2C+D%27Agostino+RB+Sr%2C+Kubica+J%2C+Volpe+M%2C+Agewall+S%2C+Kereiakes+DJ%2C+Kelm+M.&amp;rft.au=Navarese+EP%2C+Kolodziejczak+M%2C+Schulze+V%2C+Gurbel+PA%2C+Tantry+U%2C+Lin+Y%2C+Brockmeyer+M%2C+Kandzari+DE%2C+Kubica+JM%2C+D%27Agostino+RB+Sr%2C+Kubica+J%2C+Volpe+M%2C+Agewall+S%2C+Kereiakes+DJ%2C+Kelm+M.&amp;rft.date=7+July+2015&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fannals.org%2Farticle.aspx%3FarticleID%3D2279798&amp;rft_id=info%3Adoi%2F10.7326%2FM14-2957&amp;rft_id=info%3Apmid%2F25915661&amp;rft.issue=1&amp;rft.jtitle=Ann+Intern+Med&amp;rft.pages=40-51&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=163" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-NCCIH-45"><span class="mw-cite-backlink"><b><a href="#cite_ref-NCCIH_45-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Barnes PM, Powell-Griner E, McFann K, Nahin RL (May 27, 2004). <a rel="nofollow" class="external text" href="http://nccih.nih.gov/news/report.pdf">"Complementary and Alternative Medicine Use Among Adults: United States, 2002"</a> <span style="font-size:85%;">(PDF)</span>. <i>Advance Data from Vital and Health Statistics</i>. <a rel="nofollow" class="external free" href="http://nccih.nih.gov/news/2004/052704.htm">http://nccih.nih.gov/news/2004/052704.htm</a> (343): 6–9<span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Complementary+and+Alternative+Medicine+Use+Among+Adults%3A+United+States%2C+2002&amp;rft.au=Barnes+PM%2C+Powell-Griner+E%2C+McFann+K%2C+Nahin+RL&amp;rft.aulast=Barnes+PM%2C+Powell-Griner+E%2C+McFann+K%2C+Nahin+RL&amp;rft.date=May+27%2C+2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fnccih.nih.gov%2Fnews%2Freport.pdf&amp;rft.issue=343&amp;rft.jtitle=Advance+Data+from+Vital+and+Health+Statistics&amp;rft.pages=6-9&amp;rft.series=http%3A%2F%2Fnccih.nih.gov%2Fnews%2F2004%2F052704.htm&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-PMID1909-46"><span class="mw-cite-backlink"><b><a href="#cite_ref-PMID1909_46-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Demonty I, Ras RT, van der Knaap HC, Duchateau GS, Meijer L, Zock PL, Geleijnse JM, Trautwein EA (February 2009). "Continuous dose-response relationship of the LDL-cholesterol-lowering effect of phytosterol intake". <i><a href="/wiki/J_Nutr" title="J Nutr" class="mw-redirect">J Nutr</a></i> <b>139</b> (2): 271–84. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.3945%2Fjn.108.095125">10.3945/jn.108.095125</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19091798">19091798</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Continuous+dose-response+relationship+of+the+LDL-cholesterol-lowering+effect+of+phytosterol+intake&amp;rft.au=Demonty+I%2C+Ras+RT%2C+van+der+Knaap+HC%2C+Duchateau+GS%2C+Meijer+L%2C+Zock+PL%2C+Geleijnse+JM%2C+Trautwein+EA&amp;rft.aulast=Demonty+I%2C+Ras+RT%2C+van+der+Knaap+HC%2C+Duchateau+GS%2C+Meijer+L%2C+Zock+PL%2C+Geleijnse+JM%2C+Trautwein+EA&amp;rft.date=February+2009&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.3945%2Fjn.108.095125&amp;rft_id=info%3Apmid%2F19091798&amp;rft.issue=2&amp;rft.jtitle=J+Nutr&amp;rft.pages=271-84&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=139" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-Wein2009-47"><span class="mw-cite-backlink"><b><a href="#cite_ref-Wein2009_47-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Weingärtner O.; Bohm, M.; Laufs, U. et al. (2009). <a rel="nofollow" class="external text" href="http://eurheartj.oxfordjournals.org/cgi/content/extract/30/4/404">"Controversial role of plant sterol esters in the management of hypercholesterolaemia"</a>. <i>European Heart Journal</i> <b>30</b> (4): 404–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1093%2Feurheartj%2Fehn580">10.1093/eurheartj/ehn580</a>. <a href="/wiki/PubMed_Central" title="PubMed Central">PMC</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pmc/articles/PMC2642922">2642922</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/19158117">19158117</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Controversial+role+of+plant+sterol+esters+in+the+management+of+hypercholesterolaemia&amp;rft.au=Bohm%2C+M.&amp;rft.aulast=Weing%C3%A4rtner+O.&amp;rft.au=Laufs%2C+U.&amp;rft.au=Weing%C3%A4rtner+O.&amp;rft.date=2009&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Feurheartj.oxfordjournals.org%2Fcgi%2Fcontent%2Fextract%2F30%2F4%2F404&amp;rft_id=info%3Adoi%2F10.1093%2Feurheartj%2Fehn580&amp;rft_id=info%3Apmc%2F2642922&amp;rft_id=info%3Apmid%2F19158117&amp;rft.issue=4&amp;rft.jtitle=European+Heart+Journal&amp;rft.pages=404-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=30" class="Z3988"><span style="display:none;">&#160;</span></span> <span class="citation-comment" style="display:none; color:#33aa33">CS1 maint: Explicit use of et al. (<a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">link</a>)</span></span></li>
<li id="cite_note-48"><span class="mw-cite-backlink"><b><a href="#cite_ref-48">^</a></b></span> <span class="reference-text"><span class="citation web">Carrol, Margaret (April 2012). <a rel="nofollow" class="external text" href="http://www.cdc.gov/nchs/data/databriefs/db92.pdf">"Total and High-density Lipoprotein Cholesterol in Adults: National Health and Nutrition Examination Survey, 2009–2010"</a> <span style="font-size:85%;">(PDF)</span>. CDC.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.au=Carrol%2C+Margaret&amp;rft.aufirst=Margaret&amp;rft.aulast=Carrol&amp;rft.btitle=Total+and+High-density+Lipoprotein+Cholesterol+in+Adults%3A++National+Health+and+Nutrition+Examination+Survey%2C++2009%E2%80%932010&amp;rft.date=April+2012&amp;rft.genre=book&amp;rft_id=http%3A%2F%2Fwww.cdc.gov%2Fnchs%2Fdata%2Fdatabriefs%2Fdb92.pdf&amp;rft.pub=CDC&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15358046-49"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15358046_49-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Grundy SM, Cleeman JI, Merz CN, Brewer HB, Clark LT, Hunninghake DB, Pasternak RC, Smith SC, Stone NJ (2004). "Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines". <i>J Am Coll Cardiol</i> <b>44</b> (3): 720–32. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1016%2Fj.jacc.2004.07.001">10.1016/j.jacc.2004.07.001</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15358046">15358046</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Implications+of+recent+clinical+trials+for+the+National+Cholesterol+Education+Program+Adult+Treatment+Panel+III+Guidelines&amp;rft.au=Grundy+SM%2C+Cleeman+JI%2C+Merz+CN%2C+Brewer+HB%2C+Clark+LT%2C+Hunninghake+DB%2C+Pasternak+RC%2C+Smith+SC%2C+Stone+NJ&amp;rft.aulast=Grundy+SM%2C+Cleeman+JI%2C+Merz+CN%2C+Brewer+HB%2C+Clark+LT%2C+Hunninghake+DB%2C+Pasternak+RC%2C+Smith+SC%2C+Stone+NJ&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.1016%2Fj.jacc.2004.07.001&amp;rft_id=info%3Apmid%2F15358046&amp;rft.issue=3&amp;rft.jtitle=J+Am+Coll+Cardiol&amp;rft.pages=720-32&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=44" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid17015870-50"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid17015870_50-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Hayward, RA; Hofer, TP; Vijan, S (2006). "Narrative review: lack of evidence for recommended low-density lipoprotein treatment targets: a solvable problem". <i>Ann Intern Med</i> <b>145</b> (7): 520–30. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.7326%2F0003-4819-145-7-200610030-00010">10.7326/0003-4819-145-7-200610030-00010</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/17015870">17015870</a>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Narrative+review%3A+lack+of+evidence+for+recommended+low-density+lipoprotein+treatment+targets%3A+a+solvable+problem&amp;rft.aufirst=RA&amp;rft.au=Hayward%2C+RA&amp;rft.au=Hofer%2C+TP&amp;rft.aulast=Hayward&amp;rft.au=Vijan%2C+S&amp;rft.date=2006&amp;rft.genre=article&amp;rft_id=info%3Adoi%2F10.7326%2F0003-4819-145-7-200610030-00010&amp;rft_id=info%3Apmid%2F17015870&amp;rft.issue=7&amp;rft.jtitle=Ann+Intern+Med&amp;rft.pages=520-30&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=145" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-AMDAten-51"><span class="mw-cite-backlink">^ <a href="#cite_ref-AMDAten_51-0"><sup><i><b>a</b></i></sup></a> <a href="#cite_ref-AMDAten_51-1"><sup><i><b>b</b></i></sup></a> <a href="#cite_ref-AMDAten_51-2"><sup><i><b>c</b></i></sup></a> <a href="#cite_ref-AMDAten_51-3"><sup><i><b>d</b></i></sup></a></span> <span class="reference-text"><span id="CITEREFAMDA_.E2.80.93_The_Society_for_Post-Acute_and_Long-Term_Care_Medicine2014" class="citation"><a href="/wiki/AMDA_%E2%80%93_The_Society_for_Post-Acute_and_Long-Term_Care_Medicine" title="AMDA – The Society for Post-Acute and Long-Term Care Medicine">AMDA – The Society for Post-Acute and Long-Term Care Medicine</a> (February 2014), <a rel="nofollow" class="external text" href="http://www.choosingwisely.org/doctor-patient-lists/amda/">"Ten Things Physicians and Patients Should Question"</a>, <i><a href="/wiki/Choosing_Wisely" title="Choosing Wisely">Choosing Wisely</a>: an initiative of the <a href="/wiki/ABIM_Foundation" title="ABIM Foundation">ABIM Foundation</a></i> (AMDA – The Society for Post-Acute and Long-Term Care Medicine)<span class="reference-accessdate">, retrieved <span class="nowrap">20 April</span> 2015</span></span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Ten+Things+Physicians+and+Patients+Should+Question&amp;rft.au=AMDA+%E2%80%93+The+Society+for+Post-Acute+and+Long-Term+Care+Medicine&amp;rft.aulast=AMDA+%E2%80%93+The+Society+for+Post-Acute+and+Long-Term+Care+Medicine&amp;rft.date=February+2014&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.choosingwisely.org%2Fdoctor-patient-lists%2Famda%2F&amp;rft.jtitle=Choosing+Wisely%3A+an+initiative+of+the+ABIM+Foundation&amp;rft.pub=AMDA+%E2%80%93+The+Society+for+Post-Acute+and+Long-Term+Care+Medicine&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15096336-52"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15096336_52-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Snow V, Aronson M, Hornbake E, Mottur-Pilson C, Weiss K (2004). <a rel="nofollow" class="external text" href="http://www.annals.org/cgi/content/full/140/8/644">"Lipid control in the management of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians"</a>. <i>Ann Intern Med</i> <b>140</b> (8): 644–9. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1059%2F0003-4819-140-8-200404200-00012">10.1059/0003-4819-140-8-200404200-00012</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15096336">15096336</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Lipid+control+in+the+management+of+type+2+diabetes+mellitus%3A+a+clinical+practice+guideline+from+the+American+College+of+Physicians&amp;rft.aulast=Snow+V%2C+Aronson+M%2C+Hornbake+E%2C+Mottur-Pilson+C%2C+Weiss+K&amp;rft.au=Snow+V%2C+Aronson+M%2C+Hornbake+E%2C+Mottur-Pilson+C%2C+Weiss+K&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.annals.org%2Fcgi%2Fcontent%2Ffull%2F140%2F8%2F644&amp;rft_id=info%3Adoi%2F10.1059%2F0003-4819-140-8-200404200-00012&amp;rft_id=info%3Apmid%2F15096336&amp;rft.issue=8&amp;rft.jtitle=Ann+Intern+Med&amp;rft.pages=644-9&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=140" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
<li id="cite_note-pmid15096337-53"><span class="mw-cite-backlink"><b><a href="#cite_ref-pmid15096337_53-0">^</a></b></span> <span class="reference-text"><span class="citation journal">Vijan, S; Hayward, RA; American College Of, Physicians (2004). <a rel="nofollow" class="external text" href="http://www.annals.org/cgi/content/full/140/8/650">"Pharmacologic lipid-lowering therapy in type 2 diabetes mellitus: background paper for the American College of Physicians"</a>. <i>Ann Intern Med</i> <b>140</b> (8): 650–8. <a href="/wiki/Digital_object_identifier" title="Digital object identifier">doi</a>:<a rel="nofollow" class="external text" href="//dx.doi.org/10.1059%2F0003-4819-140-8-200404200-00013">10.1059/0003-4819-140-8-200404200-00013</a>. <a href="/wiki/PubMed_Identifier" title="PubMed Identifier" class="mw-redirect">PMID</a>&#160;<a rel="nofollow" class="external text" href="//www.ncbi.nlm.nih.gov/pubmed/15096337">15096337</a><span class="reference-accessdate">. Retrieved <span class="nowrap">2010-11-04</span></span>.</span><span title="ctx_ver=Z39.88-2004&amp;rfr_id=info%3Asid%2Fen.wikipedia.org%3AHypercholesterolemia&amp;rft.atitle=Pharmacologic+lipid-lowering+therapy+in+type+2+diabetes+mellitus%3A+background+paper+for+the+American+College+of+Physicians&amp;rft.au=American+College+Of%2C+Physicians&amp;rft.aufirst=S&amp;rft.au=Hayward%2C+RA&amp;rft.aulast=Vijan&amp;rft.au=Vijan%2C+S&amp;rft.date=2004&amp;rft.genre=article&amp;rft_id=http%3A%2F%2Fwww.annals.org%2Fcgi%2Fcontent%2Ffull%2F140%2F8%2F650&amp;rft_id=info%3Adoi%2F10.1059%2F0003-4819-140-8-200404200-00013&amp;rft_id=info%3Apmid%2F15096337&amp;rft.issue=8&amp;rft.jtitle=Ann+Intern+Med&amp;rft.pages=650-8&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.volume=140" class="Z3988"><span style="display:none;">&#160;</span></span></span></li>
</ol>
</div>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Lipid_metabolism_disorders" title="Template:Lipid metabolism disorders"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Lipid_metabolism_disorders" title="Template talk:Lipid metabolism disorders"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Lipid_metabolism_disorders&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%"><a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">Inborn error</a> of <a href="/wiki/Inborn_error_of_lipid_metabolism" title="Inborn error of lipid metabolism">lipid metabolism</a>: <a href="/wiki/Dyslipidemia" title="Dyslipidemia">dyslipidemia</a> (<a href="/wiki/ICD-10_Chapter_IV:_Endocrine,_nutritional_and_metabolic_diseases#.28E75.29_Lipids" title="ICD-10 Chapter IV: Endocrine, nutritional and metabolic diseases">E78</a>, <a href="/wiki/List_of_ICD-9_codes_240%E2%80%93279:_endocrine,_nutritional_and_metabolic_diseases,_and_immunity_disorders#Other_metabolic_and_immunity_disorders_.28270.E2.80.93279.29" title="List of ICD-9 codes 240–279: endocrine, nutritional and metabolic diseases, and immunity disorders">272.0–272.6</a>)</div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hyperlipidemia" title="Hyperlipidemia">Hyperlipidemia</a></th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><strong class="selflink">Hypercholesterolemia</strong>/<a href="/wiki/Hypertriglyceridemia" title="Hypertriglyceridemia">Hypertriglyceridemia</a>
<ul>
<li><a href="/wiki/Lipoprotein_lipase_deficiency" title="Lipoprotein lipase deficiency">Lipoprotein lipase deficiency/Type Ia</a></li>
<li><a href="/wiki/Familial_apoprotein_CII_deficiency" title="Familial apoprotein CII deficiency" class="mw-redirect">Familial apoprotein CII deficiency/Type Ib</a></li>
<li><a href="/wiki/Familial_hypercholesterolemia" title="Familial hypercholesterolemia">Familial hypercholesterolemia/Type IIa</a></li>
<li><a href="/wiki/Combined_hyperlipidemia" title="Combined hyperlipidemia">Combined hyperlipidemia/Type IIb</a></li>
<li><a href="/wiki/Familial_dysbetalipoproteinemia" title="Familial dysbetalipoproteinemia">Familial dysbetalipoproteinemia/Type III</a></li>
<li><a href="/wiki/Familial_hypertriglyceridemia" title="Familial hypertriglyceridemia">Familial hypertriglyceridemia/Type IV</a></li>
</ul>
</li>
<li><a href="/wiki/Xanthoma" title="Xanthoma">Xanthoma/Xanthomatosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypolipoproteinemia" title="Hypolipoproteinemia">Hypolipoproteinemia</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em"></div>
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypoalphalipoproteinemia" title="Hypoalphalipoproteinemia">Hypoalphalipoproteinemia/HDL</a></th>
<td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lecithin_cholesterol_acyltransferase_deficiency" title="Lecithin cholesterol acyltransferase deficiency">Lecithin cholesterol acyltransferase deficiency</a></li>
<li><a href="/wiki/Tangier_disease" title="Tangier disease">Tangier disease</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Hypobetalipoproteinemia" title="Hypobetalipoproteinemia">Hypobetalipoproteinemia/LDL</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Abetalipoproteinemia" title="Abetalipoproteinemia">Abetalipoproteinemia</a></li>
<li><a href="/wiki/Apolipoprotein_B_deficiency" title="Apolipoprotein B deficiency">Apolipoprotein B deficiency</a></li>
<li><a href="/wiki/Chylomicron_retention_disease" title="Chylomicron retention disease">Chylomicron retention disease</a></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Lipodystrophy" title="Lipodystrophy">Lipodystrophy</a></th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Barraquer%E2%80%93Simons_syndrome" title="Barraquer–Simons syndrome">Barraquer–Simons syndrome</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Other</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Lipomatosis" title="Lipomatosis">Lipomatosis</a></li>
<li><a href="/wiki/Adiposis_dolorosa" title="Adiposis dolorosa">Adiposis dolorosa</a></li>
<li><a href="/wiki/Urbach%E2%80%93Wiethe_disease" title="Urbach–Wiethe disease">Lipoid proteinosis</a></li>
<li><a href="/wiki/Familial_renal_amyloidosis" title="Familial renal amyloidosis">APOA1 familial renal amyloidosis</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;">
<table class="nowraplinks navbox-subgroup" style="border-spacing:0">
<tr>
<th scope="col" class="navbox-title" colspan="2">
<div class="plainlinks hlist navbar mini">
<ul>
<li class="nv-view"><a href="/wiki/Template:Metabolic_navs" title="Template:Metabolic navs"><span title="View this template" style=";;background:none transparent;border:none;">v</span></a></li>
<li class="nv-talk"><a href="/wiki/Template_talk:Metabolic_navs" title="Template talk:Metabolic navs"><span title="Discuss this template" style=";;background:none transparent;border:none;">t</span></a></li>
<li class="nv-edit"><a class="external text" href="//en.wikipedia.org/w/index.php?title=Template:Metabolic_navs&amp;action=edit"><span title="Edit this template" style=";;background:none transparent;border:none;">e</span></a></li>
</ul>
</div>
<div style="font-size:110%">Index of <a href="/wiki/Inborn_error_of_metabolism" title="Inborn error of metabolism">inborn errors of metabolism</a></div>
</th>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Description</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Metabolism" title="Template:Metabolism">Metabolism</a></li>
<li>Enzymes and pathways: <a href="/wiki/Template:Citric_acid_cycle" title="Template:Citric acid cycle">citric acid cycle</a>
<ul>
<li><a href="/wiki/Template:Citric_acid_cycle_enzymes_and_ETC" title="Template:Citric acid cycle enzymes and ETC">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_enzymes" title="Template:Pentose phosphate pathway enzymes">pentose phosphate</a>
<ul>
<li><a href="/wiki/Template:Pentose_phosphate_pathway_intermediates" title="Template:Pentose phosphate pathway intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycoproteins" title="Template:Glycoproteins">glycoproteins</a>
<ul>
<li><a href="/wiki/Template:Glycoprotein_metabolism_enzymes" title="Template:Glycoprotein metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Glycosaminoglycans" title="Template:Glycosaminoglycans">glycosaminoglycans</a>
<ul>
<li><a href="/wiki/Template:Proteoglycan_metabolism_enzymes" title="Template:Proteoglycan metabolism enzymes">proteoglycan enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Phospholipids" title="Template:Phospholipids">phospholipid</a>
<ul>
<li><a href="/wiki/Template:Phospholipid_metabolism" title="Template:Phospholipid metabolism">metabolism</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Cholesterol_and_steroid_metabolism_enzymes" title="Template:Cholesterol and steroid metabolism enzymes">cholesterol and steroid</a>
<ul>
<li><a href="/wiki/Template:Cholesterol_and_steroid_intermediates" title="Template:Cholesterol and steroid intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Sphingolipids" title="Template:Sphingolipids">sphingolipids</a>
<ul>
<li><a href="/wiki/Template:Glycolipid/sphingolipid_metabolism_enzymes" title="Template:Glycolipid/sphingolipid metabolism enzymes" class="mw-redirect">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Eicosanoids" title="Template:Eicosanoids">eicosanoids</a>
<ul>
<li><a href="/wiki/Template:Eicosanoid_metabolism_enzymes" title="Template:Eicosanoid metabolism enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Amino_acid_metabolism_enzymes" title="Template:Amino acid metabolism enzymes">amino acid</a>
<ul>
<li><a href="/wiki/Template:Amino_acid_metabolism_intermediates" title="Template:Amino acid metabolism intermediates">intermediates</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Urea_cycle" title="Template:Urea cycle">urea cycle</a>
<ul>
<li><a href="/wiki/Template:Urea_cycle_enzymes" title="Template:Urea cycle enzymes">enzymes</a></li>
</ul>
</li>
<li><a href="/wiki/Template:Nucleotide_metabolism_enzymes" title="Template:Nucleotide metabolism enzymes">nucleotide</a>
<ul>
<li><a href="/wiki/Template:Nucleotide_metabolism_intermediates" title="Template:Nucleotide metabolism intermediates">intermediates</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Disorders</th>
<td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/Template:Disorders_of_TCA_and_ETC" title="Template:Disorders of TCA and ETC">Citric acid cycle and electron transport chain</a></li>
<li><a href="/wiki/Template:Glycoprotein_disorders" title="Template:Glycoprotein disorders">Glycoprotein</a></li>
<li><a href="/wiki/Template:Proteoglycan_disorders" title="Template:Proteoglycan disorders">Proteoglycan</a></li>
<li><a href="/wiki/Template:Fatty-acid_metabolism_disorders" title="Template:Fatty-acid metabolism disorders">Fatty-acid</a></li>
<li><a href="/wiki/Template:Phospholipid_metabolism_disorders" title="Template:Phospholipid metabolism disorders">Phospholipid</a></li>
<li><a href="/wiki/Template:Defects_of_cholesterol_and_steroid_metabolism" title="Template:Defects of cholesterol and steroid metabolism">Cholesterol and steroid</a></li>
<li><a href="/wiki/Template:Eicosanoid_metabolism_disorders" title="Template:Eicosanoid metabolism disorders">Eicosanoid</a></li>
<li><a href="/wiki/Template:Amino_acid_metabolic_pathology" title="Template:Amino acid metabolic pathology">Amino acid</a></li>
<li><a href="/wiki/Template:Inborn_errors_of_purine-pyrimidine_metabolism" title="Template:Inborn errors of purine-pyrimidine metabolism">Purine-pyrimidine</a></li>
<li><a href="/wiki/Template:Heme_metabolism_disorders" title="Template:Heme metabolism disorders">Heme metabolism</a></li>
<li><a href="/wiki/Template:Eponymous_medical_signs_for_endocrinology,_nutrition,_and_metabolism" title="Template:Eponymous medical signs for endocrinology, nutrition, and metabolism">Symptoms and signs</a></li>
</ul>
</div>
</td>
</tr>
<tr style="height:2px">
<td colspan="2"></td>
</tr>
<tr>
<th scope="row" class="navbox-group">Treatment</th>
<td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li>Drugs
<ul>
<li><a href="/wiki/Template:Other_alimentary_tract_and_metabolism_products" title="Template:Other alimentary tract and metabolism products">other</a></li>
</ul>
</li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>
</td>
</tr>
</table>
<table class="navbox" style="border-spacing:0">
<tr>
<td style="padding:2px">
<table class="nowraplinks hlist navbox-inner" style="border-spacing:0;background:transparent;color:inherit">
<tr>
<th scope="row" class="navbox-group"><a href="/wiki/Help:Authority_control" title="Help:Authority control">Authority control</a></th>
<td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px">
<div style="padding:0em 0.25em">
<ul>
<li><a href="/wiki/National_Diet_Library" title="National Diet Library">NDL</a>: <span class="uid"><a rel="nofollow" class="external text" href="http://id.ndl.go.jp/auth/ndlna/00566728">00566728</a></span></li>
</ul>
</div>
</td>
</tr>
</table>
</td>
</tr>
</table>


<!-- 
NewPP limit report
Parsed by mw1253
CPU time usage: 0.545 seconds
Real time usage: 0.656 seconds
Preprocessor visited node count: 3960/1000000
Preprocessor generated node count: 0/1500000
Post‐expand include size: 159538/2097152 bytes
Template argument size: 396/2097152 bytes
Highest expansion depth: 10/40
Expensive parser function count: 0/500
Lua time usage: 0.188/10.000 seconds
Lua memory usage: 3.4 MB/50 MB
-->

<!-- 
Transclusion expansion time report (%,ms,calls,template)
100.00%  527.539      1 - -total
 49.75%  262.450      1 - Template:Reflist
 25.28%  133.383     39 - Template:Cite_journal
 14.84%   78.287      1 - Template:Infobox_disease
 12.80%   67.513      1 - Template:Infobox
  8.37%   44.174      3 - Template:Navbox
  7.65%   40.341      1 - Template:Lipidemias
  4.46%   23.505      1 - Template:Authority_control
  3.98%   21.001      1 - Template:Metabolic_navs
  3.12%   16.470      6 - Template:Cite_web
-->

<!-- Saved in parser cache with key enwiki:pcache:idhash:513039-0!*!0!!en!4!*!math=0 and timestamp 20150711120109 and revision id 670339101
 -->
<noscript><img src="//en.wikipedia.org/wiki/Special:CentralAutoLogin/start?type=1x1" alt="" title="" width="1" height="1" style="border: none; position: absolute;" /></noscript></div>					<div class="printfooter">
						Retrieved from "<a dir="ltr" href="https://en.wikipedia.org/w/index.php?title=Hypercholesterolemia&amp;oldid=670339101">https://en.wikipedia.org/w/index.php?title=Hypercholesterolemia&amp;oldid=670339101</a>"					</div>
				<div id='catlinks' class='catlinks'><div id="mw-normal-catlinks" class="mw-normal-catlinks"><a href="/wiki/Help:Category" title="Help:Category">Categories</a>: <ul><li><a href="/wiki/Category:Cholesterol_and_steroid_metabolism_disorders" title="Category:Cholesterol and steroid metabolism disorders">Cholesterol and steroid metabolism disorders</a></li><li><a href="/wiki/Category:Lipid_metabolism_disorders" title="Category:Lipid metabolism disorders">Lipid metabolism disorders</a></li><li><a href="/wiki/Category:Medical_conditions_related_to_obesity" title="Category:Medical conditions related to obesity">Medical conditions related to obesity</a></li></ul></div><div id="mw-hidden-catlinks" class="mw-hidden-catlinks mw-hidden-cats-hidden">Hidden categories: <ul><li><a href="/wiki/Category:CS1_maint:_Explicit_use_of_et_al." title="Category:CS1 maint: Explicit use of et al.">CS1 maint: Explicit use of et al.</a></li><li><a href="/wiki/Category:Pages_containing_cite_templates_with_deprecated_parameters" title="Category:Pages containing cite templates with deprecated parameters">Pages containing cite templates with deprecated parameters</a></li><li><a href="/wiki/Category:Articles_with_contributors_link" title="Category:Articles with contributors link">Articles with contributors link</a></li><li><a href="/wiki/Category:Articles_that_use_a_Medicine_navs_subtemplate" title="Category:Articles that use a Medicine navs subtemplate">Articles that use a Medicine navs subtemplate</a></li></ul></div></div>				<div class="visualClear"></div>
							</div>
		</div>
		<div id="mw-navigation">
			<h2>Navigation menu</h2>

			<div id="mw-head">
									<div id="p-personal" role="navigation" class="" aria-labelledby="p-personal-label">
						<h3 id="p-personal-label">Personal tools</h3>
						<ul>
							<li id="pt-createaccount"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hypercholesterolemia&amp;type=signup" title="You are encouraged to create an account and log in; however, it is not mandatory">Create account</a></li><li id="pt-login"><a href="/w/index.php?title=Special:UserLogin&amp;returnto=Hypercholesterolemia" title="You're encouraged to log in; however, it's not mandatory. [o]" accesskey="o">Log in</a></li>						</ul>
					</div>
									<div id="left-navigation">
										<div id="p-namespaces" role="navigation" class="vectorTabs" aria-labelledby="p-namespaces-label">
						<h3 id="p-namespaces-label">Namespaces</h3>
						<ul>
															<li  id="ca-nstab-main" class="selected"><span><a href="/wiki/Hypercholesterolemia"  title="View the content page [c]" accesskey="c">Article</a></span></li>
															<li  id="ca-talk"><span><a href="/wiki/Talk:Hypercholesterolemia"  title="Discussion about the content page [t]" accesskey="t" rel="discussion">Talk</a></span></li>
													</ul>
					</div>
										<div id="p-variants" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-variants-label">
												<h3 id="p-variants-label">
							<span>Variants</span><a href="#"></a>
						</h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
									</div>
				<div id="right-navigation">
										<div id="p-views" role="navigation" class="vectorTabs" aria-labelledby="p-views-label">
						<h3 id="p-views-label">Views</h3>
						<ul>
															<li id="ca-view" class="selected"><span><a href="/wiki/Hypercholesterolemia" >Read</a></span></li>
															<li id="ca-edit"><span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=edit"  title="Edit this page [e]" accesskey="e">Edit</a></span></li>
															<li id="ca-history" class="collapsible"><span><a href="/w/index.php?title=Hypercholesterolemia&amp;action=history"  title="Past versions of this page [h]" accesskey="h">View history</a></span></li>
													</ul>
					</div>
										<div id="p-cactions" role="navigation" class="vectorMenu emptyPortlet" aria-labelledby="p-cactions-label">
						<h3 id="p-cactions-label"><span>More</span><a href="#"></a></h3>

						<div class="menu">
							<ul>
															</ul>
						</div>
					</div>
										<div id="p-search" role="search">
						<h3>
							<label for="searchInput">Search</label>
						</h3>

						<form action="/w/index.php" id="searchform">
							<div id="simpleSearch">
							<input type="search" name="search" placeholder="Search" title="Search Wikipedia [f]" accesskey="f" id="searchInput" /><input type="hidden" value="Special:Search" name="title" /><input type="submit" name="fulltext" value="Search" title="Search Wikipedia for this text" id="mw-searchButton" class="searchButton mw-fallbackSearchButton" /><input type="submit" name="go" value="Go" title="Go to a page with this exact name if one exists" id="searchButton" class="searchButton" />							</div>
						</form>
					</div>
									</div>
			</div>
			<div id="mw-panel">
				<div id="p-logo" role="banner"><a class="mw-wiki-logo" href="/wiki/Main_Page"  title="Visit the main page"></a></div>
						<div class="portal" role="navigation" id='p-navigation' aria-labelledby='p-navigation-label'>
			<h3 id='p-navigation-label'>Navigation</h3>

			<div class="body">
									<ul>
						<li id="n-mainpage-description"><a href="/wiki/Main_Page" title="Visit the main page [z]" accesskey="z">Main page</a></li><li id="n-contents"><a href="/wiki/Portal:Contents" title="Guides to browsing Wikipedia">Contents</a></li><li id="n-featuredcontent"><a href="/wiki/Portal:Featured_content" title="Featured content – the best of Wikipedia">Featured content</a></li><li id="n-currentevents"><a href="/wiki/Portal:Current_events" title="Find background information on current events">Current events</a></li><li id="n-randompage"><a href="/wiki/Special:Random" title="Load a random article [x]" accesskey="x">Random article</a></li><li id="n-sitesupport"><a href="https://donate.wikimedia.org/wiki/Special:FundraiserRedirector?utm_source=donate&amp;utm_medium=sidebar&amp;utm_campaign=C13_en.wikipedia.org&amp;uselang=en" title="Support us">Donate to Wikipedia</a></li><li id="n-shoplink"><a href="//shop.wikimedia.org" title="Visit the Wikimedia Shop">Wikipedia store</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-interaction' aria-labelledby='p-interaction-label'>
			<h3 id='p-interaction-label'>Interaction</h3>

			<div class="body">
									<ul>
						<li id="n-help"><a href="/wiki/Help:Contents" title="Guidance on how to use and edit Wikipedia">Help</a></li><li id="n-aboutsite"><a href="/wiki/Wikipedia:About" title="Find out about Wikipedia">About Wikipedia</a></li><li id="n-portal"><a href="/wiki/Wikipedia:Community_portal" title="About the project, what you can do, where to find things">Community portal</a></li><li id="n-recentchanges"><a href="/wiki/Special:RecentChanges" title="A list of recent changes in the wiki [r]" accesskey="r">Recent changes</a></li><li id="n-contactpage"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-tb' aria-labelledby='p-tb-label'>
			<h3 id='p-tb-label'>Tools</h3>

			<div class="body">
									<ul>
						<li id="t-whatlinkshere"><a href="/wiki/Special:WhatLinksHere/Hypercholesterolemia" title="List of all English Wikipedia pages containing links to this page [j]" accesskey="j">What links here</a></li><li id="t-recentchangeslinked"><a href="/wiki/Special:RecentChangesLinked/Hypercholesterolemia" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</a></li><li id="t-upload"><a href="/wiki/Wikipedia:File_Upload_Wizard" title="Upload files [u]" accesskey="u">Upload file</a></li><li id="t-specialpages"><a href="/wiki/Special:SpecialPages" title="A list of all special pages [q]" accesskey="q">Special pages</a></li><li id="t-permalink"><a href="/w/index.php?title=Hypercholesterolemia&amp;oldid=670339101" title="Permanent link to this revision of the page">Permanent link</a></li><li id="t-info"><a href="/w/index.php?title=Hypercholesterolemia&amp;action=info" title="More information about this page">Page information</a></li><li id="t-wikibase"><a href="//www.wikidata.org/wiki/Q762713" title="Link to connected data repository item [g]" accesskey="g">Wikidata item</a></li><li id="t-cite"><a href="/w/index.php?title=Special:CiteThisPage&amp;page=Hypercholesterolemia&amp;id=670339101" title="Information on how to cite this page">Cite this page</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-coll-print_export' aria-labelledby='p-coll-print_export-label'>
			<h3 id='p-coll-print_export-label'>Print/export</h3>

			<div class="body">
									<ul>
						<li id="coll-create_a_book"><a href="/w/index.php?title=Special:Book&amp;bookcmd=book_creator&amp;referer=Hypercholesterolemia">Create a book</a></li><li id="coll-download-as-rdf2latex"><a href="/w/index.php?title=Special:Book&amp;bookcmd=render_article&amp;arttitle=Hypercholesterolemia&amp;oldid=670339101&amp;writer=rdf2latex">Download as PDF</a></li><li id="t-print"><a href="/w/index.php?title=Hypercholesterolemia&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</a></li>					</ul>
							</div>
		</div>
			<div class="portal" role="navigation" id='p-lang' aria-labelledby='p-lang-label'>
			<h3 id='p-lang-label'>Languages</h3>

			<div class="body">
									<ul>
						<li class="interlanguage-link interwiki-ar"><a href="//ar.wikipedia.org/wiki/%D9%81%D8%B1%D8%B7_%D9%83%D9%88%D9%84%D9%8A%D8%B3%D8%AA%D8%B1%D9%88%D9%84_%D8%A7%D9%84%D8%AF%D9%85" title="فرط كوليسترول الدم – Arabic" lang="ar" hreflang="ar">العربية</a></li><li class="interlanguage-link interwiki-ca"><a href="//ca.wikipedia.org/wiki/Hipercolesterol%C3%A8mia" title="Hipercolesterolèmia – Catalan" lang="ca" hreflang="ca">Català</a></li><li class="interlanguage-link interwiki-de"><a href="//de.wikipedia.org/wiki/Hypercholesterin%C3%A4mie" title="Hypercholesterinämie – German" lang="de" hreflang="de">Deutsch</a></li><li class="interlanguage-link interwiki-el"><a href="//el.wikipedia.org/wiki/%CE%A5%CF%80%CE%B5%CF%81%CF%87%CE%BF%CE%BB%CE%B7%CF%83%CF%84%CE%B5%CF%81%CE%BF%CE%BB%CE%B1%CE%B9%CE%BC%CE%AF%CE%B1" title="Υπερχοληστερολαιμία – Greek" lang="el" hreflang="el">Ελληνικά</a></li><li class="interlanguage-link interwiki-es"><a href="//es.wikipedia.org/wiki/Hipercolesterolemia" title="Hipercolesterolemia – Spanish" lang="es" hreflang="es">Español</a></li><li class="interlanguage-link interwiki-eu"><a href="//eu.wikipedia.org/wiki/Hiperkolesterolemia" title="Hiperkolesterolemia – Basque" lang="eu" hreflang="eu">Euskara</a></li><li class="interlanguage-link interwiki-fa"><a href="//fa.wikipedia.org/wiki/%D9%87%D8%A7%DB%8C%D9%BE%D8%B1%DA%A9%D9%84%D8%B3%D8%AA%D8%B1%D9%88%D9%84%D9%85%DB%8C" title="هایپرکلسترولمی – Persian" lang="fa" hreflang="fa">فارسی</a></li><li class="interlanguage-link interwiki-fr"><a href="//fr.wikipedia.org/wiki/Hypercholest%C3%A9rol%C3%A9mie" title="Hypercholestérolémie – French" lang="fr" hreflang="fr">Français</a></li><li class="interlanguage-link interwiki-hi"><a href="//hi.wikipedia.org/wiki/%E0%A4%85%E0%A4%A4%E0%A4%BF%E0%A4%B5%E0%A4%B8%E0%A4%BE%E0%A4%B0%E0%A4%95%E0%A5%8D%E0%A4%A4%E0%A4%A4%E0%A4%BE_(%E0%A4%B9%E0%A4%BE%E0%A4%87%E0%A4%AA%E0%A4%B0%E0%A4%B2%E0%A4%BF%E0%A4%AA%E0%A5%80%E0%A4%A1%E0%A5%87%E0%A4%AE%E0%A4%BF%E0%A4%AF%E0%A4%BE)" title="अतिवसारक्तता (हाइपरलिपीडेमिया) – Hindi" lang="hi" hreflang="hi">हिन्दी</a></li><li class="interlanguage-link interwiki-id"><a href="//id.wikipedia.org/wiki/Hiperkolesterolemia" title="Hiperkolesterolemia – Indonesian" lang="id" hreflang="id">Bahasa Indonesia</a></li><li class="interlanguage-link interwiki-it"><a href="//it.wikipedia.org/wiki/Ipercolesterolemia" title="Ipercolesterolemia – Italian" lang="it" hreflang="it">Italiano</a></li><li class="interlanguage-link interwiki-he"><a href="//he.wikipedia.org/wiki/%D7%94%D7%99%D7%A4%D7%A8%D7%9B%D7%95%D7%9C%D7%A1%D7%98%D7%A8%D7%95%D7%9C%D7%9E%D7%99%D7%94" title="היפרכולסטרולמיה – Hebrew" lang="he" hreflang="he">עברית</a></li><li class="interlanguage-link interwiki-mk"><a href="//mk.wikipedia.org/wiki/%D0%A5%D0%B8%D0%BF%D0%B5%D1%80%D1%85%D0%BE%D0%BB%D0%B5%D1%81%D1%82%D0%B5%D1%80%D0%BE%D0%BB%D0%B5%D0%BC%D0%B8%D1%98%D0%B0" title="Хиперхолестеролемија – Macedonian" lang="mk" hreflang="mk">Македонски</a></li><li class="interlanguage-link interwiki-ms"><a href="//ms.wikipedia.org/wiki/Hiperkolesterolemia" title="Hiperkolesterolemia – Malay" lang="ms" hreflang="ms">Bahasa Melayu</a></li><li class="interlanguage-link interwiki-nl"><a href="//nl.wikipedia.org/wiki/Hypercholesterolemie" title="Hypercholesterolemie – Dutch" lang="nl" hreflang="nl">Nederlands</a></li><li class="interlanguage-link interwiki-ja"><a href="//ja.wikipedia.org/wiki/%E8%84%82%E8%B3%AA%E7%95%B0%E5%B8%B8%E7%97%87" title="脂質異常症 – Japanese" lang="ja" hreflang="ja">日本語</a></li><li class="interlanguage-link interwiki-pl"><a href="//pl.wikipedia.org/wiki/Hipercholesterolemia" title="Hipercholesterolemia – Polish" lang="pl" hreflang="pl">Polski</a></li><li class="interlanguage-link interwiki-pt"><a href="//pt.wikipedia.org/wiki/Hipercolesterolemia" title="Hipercolesterolemia – Portuguese" lang="pt" hreflang="pt">Português</a></li><li class="interlanguage-link interwiki-simple"><a href="//simple.wikipedia.org/wiki/Hypercholesterolemia" title="Hypercholesterolemia – Simple English" lang="simple" hreflang="simple">Simple English</a></li><li class="interlanguage-link interwiki-sk"><a href="//sk.wikipedia.org/wiki/Hypercholesterol%C3%A9mia" title="Hypercholesterolémia – Slovak" lang="sk" hreflang="sk">Slovenčina</a></li><li class="interlanguage-link interwiki-sv"><a href="//sv.wikipedia.org/wiki/Hyperkolesterolemi" title="Hyperkolesterolemi – Swedish" lang="sv" hreflang="sv">Svenska</a></li><li class="uls-p-lang-dummy"><a href="#"></a></li>					</ul>
				<div class='after-portlet after-portlet-lang'><span class="wb-langlinks-edit wb-langlinks-link"><a href="//www.wikidata.org/wiki/Q762713#sitelinks-wikipedia" title="Edit interlanguage links" class="wbc-editpage">Edit links</a></span></div>			</div>
		</div>
				</div>
		</div>
		<div id="footer" role="contentinfo">
							<ul id="footer-info">
											<li id="footer-info-lastmod"> This page was last modified on 7 July 2015, at 10:03.</li>
											<li id="footer-info-copyright">Text is available under the <a rel="license" href="//en.wikipedia.org/wiki/Wikipedia:Text_of_Creative_Commons_Attribution-ShareAlike_3.0_Unported_License">Creative Commons Attribution-ShareAlike License</a><a rel="license" href="//creativecommons.org/licenses/by-sa/3.0/" style="display:none;"></a>;
additional terms may apply.  By using this site, you agree to the <a href="//wikimediafoundation.org/wiki/Terms_of_Use">Terms of Use</a> and <a href="//wikimediafoundation.org/wiki/Privacy_policy">Privacy Policy</a>. Wikipedia® is a registered trademark of the <a href="//www.wikimediafoundation.org/">Wikimedia Foundation, Inc.</a>, a non-profit organization.</li>
									</ul>
							<ul id="footer-places">
											<li id="footer-places-privacy"><a href="//wikimediafoundation.org/wiki/Privacy_policy" title="wikimedia:Privacy policy">Privacy policy</a></li>
											<li id="footer-places-about"><a href="/wiki/Wikipedia:About" title="Wikipedia:About">About Wikipedia</a></li>
											<li id="footer-places-disclaimer"><a href="/wiki/Wikipedia:General_disclaimer" title="Wikipedia:General disclaimer">Disclaimers</a></li>
											<li id="footer-places-contact"><a href="//en.wikipedia.org/wiki/Wikipedia:Contact_us">Contact Wikipedia</a></li>
											<li id="footer-places-developers"><a href="https://www.mediawiki.org/wiki/Special:MyLanguage/How_to_contribute">Developers</a></li>
											<li id="footer-places-mobileview"><a href="//en.m.wikipedia.org/w/index.php?title=Hypercholesterolemia&amp;mobileaction=toggle_view_mobile" class="noprint stopMobileRedirectToggle">Mobile view</a></li>
									</ul>
										<ul id="footer-icons" class="noprint">
											<li id="footer-copyrightico">
							<a href="//wikimediafoundation.org/"><img src="/static/images/wikimedia-button.png" srcset="/static/images/wikimedia-button-1.5x.png 1.5x, /static/images/wikimedia-button-2x.png 2x" width="88" height="31" alt="Wikimedia Foundation"/></a>						</li>
											<li id="footer-poweredbyico">
							<a href="//www.mediawiki.org/"><img src="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" srcset="//en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_132x47.png 1.5x, //en.wikipedia.org/static/1.26wmf13/resources/assets/poweredby_mediawiki_176x62.png 2x" width="88" height="31" /></a>						</li>
									</ul>
						<div style="clear:both"></div>
		</div>
		<script>if(window.jQuery)jQuery.ready();</script><script>if(window.mw){
mw.loader.state({"ext.globalCssJs.site":"ready","ext.globalCssJs.user":"ready","site":"loading","user":"ready","user.groups":"ready"});
}</script>
<link rel="stylesheet" href="//en.wikipedia.org/w/load.php?debug=false&amp;lang=en&amp;modules=ext.cite.styles%7Cext.gadget.DRN-wizard%2CReferenceTooltips%2CWatchlistGreenIndicators%2Ccharinsert%2Cfeatured-articles-links%2CrefToolbar%2Cswitcher%2Cteahouse%7Cext.wikimediaBadges&amp;only=styles&amp;skin=vector&amp;*" />
<script>if(window.mw){
mw.loader.load(["ext.cite.a11y","mediawiki.toc","mediawiki.action.view.postEdit","mediawiki.user","mediawiki.hidpi","mediawiki.page.ready","mediawiki.searchSuggest","ext.cirrusSearch.loggingSchema","mmv.bootstrap.autostart","ext.imageMetrics.loader","ext.eventLogging.subscriber","ext.wikimediaEvents","ext.wikimediaEvents.statsd","ext.navigationTiming","ext.gadget.teahouse","ext.gadget.ReferenceTooltips","ext.gadget.WatchlistGreenIndicators","ext.gadget.DRN-wizard","ext.gadget.charinsert","ext.gadget.refToolbar","ext.gadget.switcher","ext.gadget.featured-articles-links","ext.visualEditor.targetLoader","schema.UniversalLanguageSelector","ext.uls.eventlogger","ext.uls.interlanguage"],null,true);
}</script>
<script>if(window.mw){
document.write("\u003Cscript src=\"//en.wikipedia.org/w/load.php?debug=false\u0026amp;lang=en\u0026amp;modules=site\u0026amp;only=scripts\u0026amp;skin=vector\u0026amp;*\"\u003E\u003C/script\u003E");
}</script>
<script>if(window.mw){
mw.config.set({"wgBackendResponseTime":107,"wgHostname":"mw1054"});
}</script>
	</body>
</html>
